<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2024.1346565</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Mla system and its role in maintaining outer membrane barrier function in <italic>Stenotrophomonas maltophilia</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Coves</surname>
<given-names>Xavier</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mamat</surname>
<given-names>Uwe</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/279655"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Conchillo-Sol&#xe9;</surname>
<given-names>Oscar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/698528"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huedo</surname>
<given-names>Pol</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/209411"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bravo</surname>
<given-names>Marc</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2591288"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>G&#xf3;mez</surname>
<given-names>Andromeda-Celeste</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krohn</surname>
<given-names>Ines</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/296087"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Streit</surname>
<given-names>Wolfgang R.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/231858"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaible</surname>
<given-names>Ulrich E.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/69237"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gibert</surname>
<given-names>Isidre</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/125670"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Daura</surname>
<given-names>Xavier</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/233028"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yero</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/192673"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institut de Biotecnologia i de Biomedicina (IBB), Universitat Aut&#xf2;noma de Barcelona (UAB)</institution>, <addr-line>Cerdanyola del Vall&#xe8;s</addr-line>, <country>Spain</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Departament de Gen&#xe8;tica i de Microbiologia, Universitat Aut&#xf2;noma de Barcelona (UAB)</institution>, <addr-line>Cerdanyola del Vall&#xe8;s</addr-line>, <country>Spain</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Cellular Microbiology, Priority Research Area Infections, Research Center Borstel, Leibniz Lung Center, Leibniz Research Alliance INFECTIONS</institution>, <addr-line>Borstel</addr-line>, <country>Germany</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Microbiology and Biotechnology, University Institute of Plant Science and Microbiology, of Hamburg</institution>, <addr-line>Hamburg</addr-line>, <country>Germany</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Catalan Institution for Research and Advanced Studies (ICREA)</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Bioingenier&#xed;a, Biomateriales y Nanomedicina, Instituto de Salud Carlos III</institution>, <addr-line>Cerdanyola del Vall&#xe8;s</addr-line>, <country>Spain</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Badreddine Douzi, Institut National de recherche pour l&#x2019;agriculture l&#x2019;alimentation et l&#x2019;environnement (INRAE), France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Elise Kaplan, UMS3760 Institut de Biologie et Chimie des Prot&#xe9;ines (IBCP), France</p>
<p>Nicolas Jacquier, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xavier Daura, <email xlink:href="mailto:Xavier.Daura@uab.cat">Xavier.Daura@uab.cat</email>; Daniel Yero, <email xlink:href="mailto:Daniel.Yero@uab.cat">Daniel.Yero@uab.cat</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1346565</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>11</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Coves, Mamat, Conchillo-Sol&#xe9;, Huedo, Bravo, G&#xf3;mez, Krohn, Streit, Schaible, Gibert, Daura and Yero</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Coves, Mamat, Conchillo-Sol&#xe9;, Huedo, Bravo, G&#xf3;mez, Krohn, Streit, Schaible, Gibert, Daura and Yero</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<italic>Stenotrophomonas maltophilia</italic> are ubiquitous Gram-negative bacteria found in both natural and clinical environments. It is a remarkably adaptable species capable of thriving in various environments, thanks to the plasticity of its genome and a diverse array of genes that encode a wide range of functions. Among these functions, one notable trait is its remarkable ability to resist various antimicrobial agents, primarily through mechanisms that regulate the diffusion across cell membranes. We have investigated the Mla ABC transport system of <italic>S. maltophilia</italic>, which in other Gram-negative bacteria is known to transport phospholipids across the periplasm and is involved in maintaining outer membrane homeostasis. First, we structurally and functionally characterized the periplasmic substrate-binding protein MlaC, which determines the specificity of this system. The predicted structure of the <italic>S. maltophilia</italic> MlaC protein revealed a hydrophobic cavity of sufficient size to accommodate the phospholipids commonly found in this species. Moreover, recombinant MlaC produced heterologously demonstrated the ability to bind phospholipids. Gene knockout experiments in <italic>S. maltophilia</italic> K279a revealed that the Mla system is involved in baseline resistance to antimicrobial and antibiofilm agents, especially those with divalent-cation chelating activity. Co-culture experiments with <italic>Pseudomonas aeruginosa</italic> also showed a significant contribution of this system to the cooperation between both species in the formation of polymicrobial biofilms. As suggested for other Gram-negative pathogenic microorganisms, this system emerges as an appealing target for potential combined antimicrobial therapies.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Stenotrophomonas maltophilia</italic>
</kwd>
<kwd>Mla system</kwd>
<kwd>biofilm</kwd>
<kwd>chelating agents</kwd>
<kwd>membrane permeability</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="95"/>
<page-count count="18"/>
<word-count count="10700"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Bacterial Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>
<italic>Stenotrophomonas maltophilia</italic> are Gram-negative bacteria widely distributed in the environment, characterized by an intrinsic, multidrug-resistant phenotype and substantial phylogenetic diversity (<xref ref-type="bibr" rid="B36">Gr&#xf6;schel et&#xa0;al., 2020</xref>). They are in general recognized as opportunistic human pathogens causing a wide range of infections (<xref ref-type="bibr" rid="B14">Brooke, 2021</xref>). In the clinical environment, these bacteria are often found colonizing the surface of medical devices, causing respiratory and urinary tract infections, especially in immunocompromised individuals or long-term hospital patients (<xref ref-type="bibr" rid="B56">Majumdar et&#xa0;al., 2022</xref>). Their virulence factors include extracellular enzymes, outer membrane (OM) proteins, outer membrane vesicles (OMV), lipopolysaccharides (LPS), fimbriae, flagella, adhesins, iron acquisition mechanisms, and the capacity to form biofilms (<xref ref-type="bibr" rid="B86">Trifonova and Strateva, 2019</xref>; <xref ref-type="bibr" rid="B14">Brooke, 2021</xref>). The best treatment for these infections is based on the combination trimethoprim/sulfamethoxazole, and more recently the use of minocycline, tigecycline, fluoroquinolones, and cefiderocol has also been recommended (<xref ref-type="bibr" rid="B59">Maraolo et&#xa0;al., 2023</xref>). Although they are considered low-virulence bacteria and therapeutic treatments are available, their intrinsic antimicrobial resistance and ability to form biofilms complicate the treatment of infections with <italic>S. maltophilia</italic>. In particular, the formation of highly heterogeneous biofilm on invasive devices, such as endotracheal tubes, catheters and central venous lines, increases its incidence as a nosocomial pathogen (<xref ref-type="bibr" rid="B32">Flores-Trevi&#xf1;o et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B4">Alio et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B14">Brooke, 2021</xref>).</p>
<p>
<italic>S. maltophilia</italic> is a model multidrug-resistant (MDR) organism with a variety of intrinsic resistance mechanisms (<xref ref-type="bibr" rid="B34">Gil-Gil et&#xa0;al., 2020</xref>). This MDR profile is an evolutionary consequence of the highly competitive environment in which these bacteria normally live, such as soil and especially the rhizosphere. Their intrinsic resistome includes, as in most MDR Gram-negative bacteria (<xref ref-type="bibr" rid="B66">Olivares et&#xa0;al., 2013</xref>), antibiotic inactivation genes, efflux pumps, resistance alleles or paralogs, and cell wall modification mechanisms. In fact, a reduced OM permeability is considered to be one of the major mechanisms of antimicrobial resistance in <italic>S. maltophilia</italic> (<xref ref-type="bibr" rid="B78">S&#xe1;nchez, 2015</xref>; <xref ref-type="bibr" rid="B14">Brooke, 2021</xref>). Acquired and adaptive resistance to antibiotics also shapes the MDR phenotype of <italic>S. maltophilia</italic> strains, e.g., acquisition of new resistance genes by horizontal gene transfer, chromosomal mutations, transient regulation of gene expression, mechanisms of heteroresistance, OMV release, or biofilm formation (<xref ref-type="bibr" rid="B23">Devos et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B78">S&#xe1;nchez, 2015</xref>; <xref ref-type="bibr" rid="B61">Mart&#xed;nez-Servat et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B34">Gil-Gil et&#xa0;al., 2020</xref>). The intrinsic resistance of <italic>S. maltophilia</italic> also extends to its interaction with other organisms. For example, <italic>S. maltophilia</italic> can cooperate in the formation of mixed biofilms with species that are highly competitive, such as <italic>Pseudomonas aeruginosa</italic>, <italic>Staphylococcus aureus</italic> and <italic>Candida albicans</italic> (<xref ref-type="bibr" rid="B62">McDaniel et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B5">Alio et&#xa0;al., 2023</xref>). Overall, the OM of <italic>S. maltophilia</italic> can be considered an important attribute of antimicrobial resistance and pathogenesis, and it also plays a role in the ecophysiology and adaptation to competitive environments. Therefore, the mechanisms that maintain the composition and integrity of the OM of <italic>S. maltophilia</italic> are key to survival and protection against external stressors.</p>    <p>Membrane phospholipid (PL) homeostasis in Gram-negative bacteria is fundamentally based on the enzymatic degradation or modification of glycerophospholipids and their transport between the inner and outer membranes (<xref ref-type="bibr" rid="B73">Powers and Trent, 2019</xref>; <xref ref-type="bibr" rid="B55">Lundstedt et&#xa0;al., 2021</xref>). These mechanisms guarantee not only the PL ratio between the two membranes, but also the asymmetry in the composition of PLs between the inner and outer leaflets of the OM. This asymmetry is essential to maintain the mechanical strength, fluidity and permeability of the OM (<xref ref-type="bibr" rid="B65">Nikaido, 2003</xref>). The OM of Gram-negative bacteria is their first line of defense, for example, to escape the effects of antimicrobials, detergents, and other harmful compounds (<xref ref-type="bibr" rid="B72">Powers and Trent, 2018</xref>). One of the known mechanisms of membrane homeostasis is the Maintenance of lipid asymmetry (Mla) system, which has been implicated in both retrograde and anterograde PL transport across the two membranes (<xref ref-type="bibr" rid="B49">Hughes et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B81">Tang et&#xa0;al., 2021</xref>). This system was originally discovered in <italic>Escherichia coli</italic> (<xref ref-type="bibr" rid="B57">Malinverni and Silhavy, 2009</xref>), and orthologous systems have been studied in various Gram-negative bacteria (<xref ref-type="bibr" rid="B75">Roier et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B12">Bernier et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B9">Baarda et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B52">Kamischke et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>). It consists of the inner membrane ABC transporter MlaFEDB, the soluble periplasmic PL-binding component MlaC, and the OM protein MlaA/VacJ (<xref ref-type="bibr" rid="B57">Malinverni and Silhavy, 2009</xref>; <xref ref-type="bibr" rid="B18">Chong et&#xa0;al., 2015</xref>). Several studies have demonstrated that MlaC can indeed bind PL and have provided mechanistic information on how this protein transfers PL between other components of the Mla system (<xref ref-type="bibr" rid="B27">Ercan et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Hughes et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B92">Yeow et&#xa0;al., 2023</xref>).</p>
<p>In this study, we investigated the homologous Mla system in <italic>S. maltophilia</italic> and its effect on resistance and virulence phenotypes in these bacteria. First, we characterized the periplasmic substrate-binding protein MlaC and its potential role in PL transport and membrane homeostasis in <italic>S. maltophilia</italic>. Based on mutational studies of the <italic>mla</italic> operon, we confirmed the contribution of the Mla system to the intrinsic resistance of <italic>S. maltophilia</italic> to certain membrane-damaging compounds and also to biofilm formation in the presence of sub-inhibitory concentrations of cation chelators. In addition, the role of this system in interspecific competition between <italic>S. maltophilia</italic> and <italic>P. aeruginosa</italic> during polymicrobial biofilm formation was investigated.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Bacterial strains and growth conditions</title>
<p>Bacterial strains used in this study are listed in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. <italic>S. maltophilia</italic> K279a (<xref ref-type="bibr" rid="B1">Abda et&#xa0;al., 2015</xref>) was used as a model strain to investigate the role of the <italic>mla</italic> operon in this species. <italic>P. aeruginosa</italic> PAO1 was used in competition and polymicrobial biofilm formation assays. Unless otherwise stated, all strains were routinely grown at 37&#xb0;C in Miller&#x2019;s LB medium (1% tryptone, 0.5% yeast extract, 1% NaCl) at 200 rpm on a rotatory shaker, or on LB supplemented with 1.5% (w/v) agar (LBA), except <italic>E. coli</italic> SM10 (&#x3bb;<italic>pir</italic>)/pUX-BF13 (<xref ref-type="bibr" rid="B10">Bao et&#xa0;al., 1991</xref>) that was routinely cultured at 30&#xb0;C. For biofilm formation assays, Brain Heart Infusion (BHI) broth from Oxoid (cat. No. CM1135) or modified BM2-glucose minimal medium (<xref ref-type="bibr" rid="B69">Overhage et&#xa0;al., 2007</xref>) (62&#x2009;mM potassium phosphate buffer, pH 7.0, 2&#x2009;mM MgSO<sub>4</sub>, 10&#x2009;&#x3bc;M FeSO<sub>4</sub>, 0.4% glucose, supplemented with 0.5% casamino acids) was used. In general, bacterial growth was measured in a Novaspec II spectrophotometer at 600 nm (OD<sub>600nm</sub>). When necessary, antibiotics were added to the agar plates at the indicated concentration.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Bacterial strains and plasmids used in this work.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Strain or plasmid</th>
<th valign="top" align="left">Genotype and/or <break/>relevant characteristics</th>
<th valign="top" align="left">Reference or source</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" colspan="3" align="left">Strains</th>
</tr>
<tr>
<th valign="top" colspan="3" align="left">
<italic>Stenotrophomonas maltophilia</italic>
</th>
</tr>
<tr>
<td valign="top" align="left">K279a</td>
<td valign="top" align="left">Wild-type. Clinical isolate and the genetic reference strain</td>
<td valign="top" align="left">Laboratory collection and (<xref ref-type="bibr" rid="B1">Abda et&#xa0;al., 2015</xref>)</td>
</tr>
<tr>
<td valign="bottom" align="left">&#x394;<italic>mlaF-B</italic>
</td>
<td valign="bottom" align="left">K279a&#x394;<italic>mlaF-B</italic> (mutant for <italic>mlaF-B</italic> genes)</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<td valign="bottom" align="left">&#x394;<italic>mlaA</italic>
</td>
<td valign="bottom" align="left">K279a&#x394;<italic>mlaA</italic> (mutant for the <italic>mlaA</italic>/<italic>vacJ</italic> gene)</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<td valign="top" align="left">K279a::sfGFP</td>
<td valign="top" align="left">sfGFP-tagged strain K279a</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B58">Mamat et&#xa0;al., 2023</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x394;<italic>mlaF-B</italic>::sfGFP</td>
<td valign="top" align="left">sfGFP-tagged strain K279a &#x394;<italic>mlaF-B</italic>
</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<th valign="top" colspan="3" align="left">
<italic>Xanthomonas campestris pv. campestris</italic>
</th>
</tr>
<tr>
<td valign="top" align="left">8523 pL6engGUS</td>
<td valign="top" align="left">
<italic>rpfF</italic> mutant, plasmid pLAFR6 carrying <italic>engXCA</italic>:<italic>gusA</italic> fusion. DSF-reporter strain</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B79">Slater et&#xa0;al., 2000</xref>)</td>
</tr>
<tr>
<th valign="top" colspan="3" align="left">
<italic>Escherichia coli</italic>
</th>
</tr>
<tr>
<td valign="top" align="left">DH5&#x3b1;</td>
<td valign="top" align="left">F<sup>-</sup> &#x3a6;80<italic>lacZ</italic>&#x394;M15 &#x394;(<italic>lacZYA-argF</italic>) U169 <italic>recA1 endA1 hsdR17</italic>(r<sub>K</sub>
<sup>-</sup> m<sub>K</sub>
<sup>+</sup>) <italic>phoA supE44 thi-1 gyrA96 relA1</italic>&#x3bb;<sup>-</sup>
</td>
<td valign="top" align="left">Laboratory collection and (<xref ref-type="bibr" rid="B40">Hanahan, 1983</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">SY327</td>
<td valign="top" align="left">&#x394;(<italic>lac pro</italic>) <italic>argE</italic>(<italic>Am</italic>) <italic>recA56 rifR nalA</italic> &#x3bb; <italic>pir</italic>
</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B63">Miller and Mekalanos, 1988</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">BL21(DE3) pLysS</td>
<td valign="top" align="left">F<sup>&#x2013;</sup>, <italic>ompT</italic>, <italic>hsdSB</italic> (rB<sup>&#x2013;</sup>, mB<sup>&#x2013;</sup>), <italic>dcm</italic>, <italic>gal</italic>, &#x3bb;(DE3), pLysS, Cm<sup>r</sup>
</td>
<td valign="top" align="left">Novagen</td>
</tr>
<tr>
<th valign="top" colspan="3" align="left">
<italic>Pseudomonas aeruginosa</italic>
</th>
</tr>
<tr>
<td valign="top" align="left">PAO1</td>
<td valign="top" align="left">Wild-type and genetic reference strain</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">PAO1:: tdTomato</td>
<td valign="top" align="left">tdTomato-tagged strain PAO1</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<th valign="top" colspan="3" align="left">Plasmids</th>
</tr>
<tr>
<td valign="top" align="left">pGPI-SceI-XCm</td>
<td valign="top" align="left">Mobilizable suicide vector; carries the R6K&#x3b3; origin of replication, the I-SceI recognition site and a <italic>xylE</italic> reporter gene, Cm<sup>r</sup>, Tp<sup>r</sup>
</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B39">Hamad et&#xa0;al., 2010</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">p&#x394;<italic>mlaF-B</italic>-US&#x2019;DS&#x2019;</td>
<td valign="top" align="left">pGPI-SceI-XCm containing the upstream and downstream flanking DNA regions of the genes <italic>mlaF-B</italic> (<italic>smlt4670-4674</italic>)</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<td valign="top" align="left">p&#x394;<italic>mlaA</italic>-US&#x2019;DS&#x2019;</td>
<td valign="top" align="left">pGPI-SceI-XCm containing the upstream and downstream flanking DNA regions of the <italic>mlaA</italic> (<italic>smlt4675</italic>) gene</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<td valign="top" align="left">pRK2013</td>
<td valign="top" align="left">RK2-derived helper plasmid carrying the <italic>tra</italic> and <italic>mob</italic> genes for mobilization of plasmids containing <italic>oriT</italic>, Kan<sup>r</sup>
</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B30">Figurski and Helinski, 1979</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">pUX-BF13</td>
<td valign="top" align="left">R6K&#x3b3;-based helper plasmid containing the Tn<italic>7</italic> transposase genes tnsABCDE for transposition of mini-Tn<italic>7</italic> elements, Amp<sup>r</sup>
</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B10">Bao et&#xa0;al., 1991</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">pDAI-SceI-SacB</td>
<td valign="top" align="left">Mobilizable broad-host range plasmid; carries the gene for the I-SceI homing endonuclease and the <italic>sacB</italic> gene, Tet<sup>r</sup>
</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B31">Flannagan et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B39">Hamad et&#xa0;al., 2010</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">pBBR1MCS1</td>
<td valign="top" align="left">Broad-host range cloning vector used for complementation, low copy, Cm<sup>r</sup>
</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B53">Kovach et&#xa0;al., 1994</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">pBBR1MCS1-<italic>mlaF-B</italic>
</td>
<td valign="top" align="left">pBBR1MCS-1 with genes <italic>smlt4670-4674</italic> inserted between sites <italic>Xba</italic>I and <italic>HindIII</italic>, Cm<sup>r</sup>
</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<td valign="top" align="left">pBAD18-Cm</td>
<td valign="top" align="left">Expression vector containing the arabinose pBAD promoter and <italic>araC</italic>, Cm<sup>r</sup>
</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B38">Guzman et&#xa0;al., 1995</xref>)</td>
</tr>
<tr>
<td valign="bottom" align="left">pBBR1-BAD-Cm</td>
<td valign="top" align="left">pBBR1MCS1 with the pBAD18Cm cassette</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<td valign="top" align="left">pBBR1-BAD-Cm-<italic>mlaA</italic>
</td>
<td valign="top" align="left">pBBR1-pBAD-Cm with the <italic>mlaA</italic> (<italic>smlt4675</italic>) CDS inserted between sites <italic>Nhe</italic>I and <italic>Hind</italic>III, Cm<sup>r</sup>
</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<td valign="top" align="left">pET28b</td>
<td valign="top" align="left">Bacterial expression vector with T<italic>7</italic>-lacO promoter, hexa-His-tag (Nterm and Cterm) with Thrombin cleavage site (N-terminal on backbone), Kan<sup>r</sup>
</td>
<td valign="top" align="left">Novagen</td>
</tr>
<tr>
<td valign="top" align="left">pET28b-H6-MlaC</td>
<td valign="top" align="left">Plasmid for MlaC (Smlt4673) protein production in <italic>E. coli</italic>
</td>
<td valign="top" align="left">This study</td>
</tr>
<tr>
<td valign="top" align="left">pUC18T-mini-Tn7T-Gm-rpoD-sfGFP</td>
<td valign="top" align="left">Mini-Tn<italic>7</italic> delivery plasmid containing the codon-optimized gene for sfGFP, Amp<sup>r</sup>, Gm<sup>r</sup>
</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B58">Mamat et&#xa0;al., 2023</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">pUC18T-mini-Tn7T-Gm-Pc-tdTomato</td>
<td valign="top" align="left">Mini-Tn<italic>7</italic> delivery plasmids containing the codon-optimized tdTomato gene, Amp<sup>r</sup>, Gm<sup>r</sup>
</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B58">Mamat et&#xa0;al., 2023</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Construction of markerless deletion mutants and complementation</title>
<p>Markerless <italic>S. maltophilia</italic> K279a mutants were constructed using the pGPI-SceI/pDAI-SceI-SacB system, which was initially described for species of the genus <italic>Burkholderia</italic> (<xref ref-type="bibr" rid="B31">Flannagan et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B8">Aubert et&#xa0;al., 2014</xref>). Briefly, p&#x394;<italic>mlaF-B</italic>-US&#x2019;DS&#x2019; and p&#x394;<italic>mlaA-</italic>US&#x2019;DS&#x2019; deletion plasmids were derived from the mobilizable suicide vector pGPI-SceI-XCm containing upstream and downstream flanking regions of the target genes in the K279a genome and maintained in <italic>E. coli</italic> SY327 (see <xref ref-type="table" rid="T1">
<bold>Tables&#xa0;1</bold>
</xref>, <xref ref-type="table" rid="T2">
<bold>2</bold>
</xref> for plasmid construction and primer details, respectively). The deletion plasmids were then transferred to the recipient <italic>S. maltophilia</italic> K279a by triparental mating using <italic>E. coli</italic> DH5&#x3b1;/pRK2013 as a helper strain and <italic>E. coli</italic> SY327 carrying the deletion plasmid as a donor strain. The K279a co-integrates were selected at 37&#xb0;C on LBA plates containing 5 &#xb5;g/mL norfloxacin in order to counterselect against <italic>E. coli</italic> donor and helper strains and 60 &#xb5;g/mL chloramphenicol to select for K279a transconjugants. To confirm the integration of the suicide plasmids, single colonies were streaked and sprayed with 0.45 M pyrocatechol. Next, the plasmid pDAI-SceI-SacB was introduced into <italic>S. maltophilia</italic> K279a co-integrates by triparental mating using <italic>E. coli</italic> DH5&#x3b1;/pDAI-SceI-SacB and <italic>E. coli</italic> DH5&#x3b1;/pRK2013 as donor and helper strains, respectively. Transconjugants were selected at 30&#xb0;C on LBA plates containing 5 &#xb5;g/mL norfloxacin and 50 &#xb5;g/mL tetracycline. The loss of the integrated pGPI-SceI-XCm plasmid was confirmed by the absence of yellow color upon pyrocatechol exposure and susceptibility to 60 &#xb5;g/mL chloramphenicol. The presence of the mutant allele was confirmed by PCR screening and DNA sequencing. Markerless mutants were obtained by curing the plasmid pDAI-SceI-SacB using sucrose counterselection.</p>
<p>
<italic>In trans</italic> complementation of the deleted genes was achieved by cloning the entire region containing the wild-type <italic>mlaF-B</italic> operon and the <italic>mla</italic>A gene into the broad-host range plasmids pBBR1MCS1 and pBBR1-BAD-Cm, respectively. To generate the expression vector pBBR1-BAD-Cm, in which <italic>mlaA</italic> transcription is driven by the arabinose promoter, the pBAD promoter and AraC-encoding cassette from pBAD18-Cm were cloned into the vector pBBR1MCS1 on compatible <italic>Spe</italic>I/<italic>Xho</italic>I sites using standard techniques and primers pBAD18-Up and pBAD18-Lw (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Primers used in this study.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Primer</th>
<th valign="top" align="left">Sequence<xref ref-type="table-fn" rid="fnT2_1">
<sup>a</sup>
</xref> (5&#x2019;-3&#x2019;)</th>
<th valign="top" align="left">Application</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">US&#x2019;-mlaFEDCB-U</td>
<td valign="top" align="left">CCAgcggccgcACTTTTCAAATAC</td>
<td valign="top" align="left">Upstream flanking region, forward primer to create p&#x394;<italic>mlaF-B</italic>-US&#x2019;DS&#x2019;, <italic>Not</italic>I</td>
</tr>
<tr>
<td valign="top" align="left">US&#x2019;-mlaFEDCB-L</td>
<td valign="top" align="left">GGGggtaccTAACGTTTTCTAGACATCGA</td>
<td valign="top" align="left">Upstream flanking region, reverse primer to create p&#x394;<italic>mlaF-B</italic>-US&#x2019;DS&#x2019;, <italic>Kpn</italic>I</td>
</tr>
<tr>
<td valign="top" align="left">DS&#x2019;-mlaFEDCB-U</td>
<td valign="top" align="left">CGAggtaccATGAACGTAGTGCGCAC</td>
<td valign="top" align="left">Downstream flanking region, forward primer to create p&#x394;<italic>mlaF-B</italic>-US&#x2019;DS&#x2019;, <italic>Kpn</italic>I</td>
</tr>
<tr>
<td valign="top" align="left">DS&#x2019;-mlaFEDCB-L</td>
<td valign="top" align="left">GCAtctagaGTCTGGCCGAAGTCCTCAT</td>
<td valign="top" align="left">Downstream flanking region, reverse primer to create p&#x394;<italic>mlaF-B</italic>-US&#x2019;DS&#x2019;, <italic>XbaI</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">US&#x2019;-mlaA-U</td>
<td valign="top" align="left">ATTgcggccgcTCGACCCTGCTCAACATCCAG</td>
<td valign="top" align="left">Upstream flanking region, forward primer to create p&#x394;<italic>mlaA</italic>-US&#x2019;DS&#x2019;, <italic>Not</italic>I</td>
</tr>
<tr>
<td valign="top" align="left">US&#x2019;-mlaA-L</td>
<td valign="top" align="left">GCTggtaccGGAGAGTGCGCACGACGTTCA</td>
<td valign="top" align="left">Upstream flanking region, reverse primer to create p&#x394;<italic>mlaA</italic>-US&#x2019;DS&#x2019;, <italic>Kpn</italic>I</td>
</tr>
<tr>
<td valign="top" align="left">DS&#x2019;-mlaA-U</td>
<td valign="top" align="left">CTGggtaccTACAGCGACGCATGAAAAACC</td>
<td valign="top" align="left">Downstream flanking region, forward primer to create p&#x394;<italic>mlaA</italic>-US&#x2019;DS&#x2019;, <italic>Kpn</italic>I</td>
</tr>
<tr>
<td valign="top" align="left">DS&#x2019;-mlaA-L</td>
<td valign="top" align="left">GAGtctagaCGTGAGCACTTCGATCCAGGA</td>
<td valign="top" align="left">Downstream flanking region, reverse primer to create p&#x394;<italic>mlaA</italic>-US&#x2019;DS&#x2019;, <italic>XbaI</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">Ext-mlaFEDCB-U</td>
<td valign="top" align="left">CGCAACCATGAAGATGAAACT</td>
<td valign="top" align="left">Forward primer outside the deleted region for mutant verification</td>
</tr>
<tr>
<td valign="top" align="left">Ext-mlaFEDCB-L</td>
<td valign="top" align="left">CTCAGTTCGTTGTAGCCAGCC</td>
<td valign="top" align="left">Reverse primer outside the deleted region for mutant verification</td>
</tr>
<tr>
<td valign="top" align="left">Ext-mlaA-U</td>
<td valign="top" align="left">AATGGCAAGTAACGCACTGGC</td>
<td valign="top" align="left">Forward primer outside the deleted region for mutant verification</td>
</tr>
<tr>
<td valign="top" align="left">Ext-mlaA-L</td>
<td valign="top" align="left">GCTATGCTGGTGGGCCATTC</td>
<td valign="top" align="left">Reverse primer outside the deleted region for mutant verification</td>
</tr>
<tr>
<td valign="top" align="left">mlaFEDCB_Comp_U</td>
<td valign="top" align="left">AATTtctagaCCAGTGTCGCGTGCAGCCAGC</td>
<td valign="top" align="left">Forward primer for cloning genes <italic>smlt4670-4674</italic> into pBBR1MCS1 including its own promoter, <italic>XbaI</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">mlaFEDCB_Comp_L</td>
<td valign="top" align="left">GGGaagcttGCGCACGACGTTCATGTCA</td>
<td valign="top" align="left">Reverse primer for cloning genes <italic>smlt4670-4674</italic> into pBBR1MCS1, <italic>HindIII</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">mlaA_Comp_U</td>
<td valign="top" align="left">TGGtctagaTGGATCTGGCTGAGGTCGAAC</td>
<td valign="top" align="left">Forward primer for cloning gene <italic>smlt4675</italic> into pBBR1-BAD-Cm including its own promoter, <italic>XbaI</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">mlaA_Comp_L</td>
<td valign="top" align="left">TGCaagcttGAAAGGACTCAGTGCGTC</td>
<td valign="top" align="left">Reverse primer for cloning gene <italic>smlt4675</italic> into pBBR1-BAD-Cm, <italic>HindIII</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">pBAD18-Up<xref ref-type="table-fn" rid="fnT2_2">
<sup>b</sup>
</xref>
</td>
<td valign="top" align="left">CCCactagtATGTCGGCGATATAG</td>
<td valign="top" align="left">Forward primer for cloning pBAD promoter and <italic>araC</italic> from pBAD18-Cm into pBBR1MCS1, <italic>SpeI</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">pBAD18-Lw<xref ref-type="table-fn" rid="fnT2_2">
<sup>b</sup>
</xref>
</td>
<td valign="top" align="left">ATGctcgagGGAAATGTTGAATAC</td>
<td valign="top" align="left">Reverse primer for cloning pBAD promoter and <italic>araC</italic> from pBAD18-Cm into pBBR1MCS1, <italic>XhoI</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">MlaC_His_Up</td>
<td valign="top" align="left">CGGtcatgaGCCATCATCATCATCATCATGCCGCCGCCCCCGCCGCT</td>
<td valign="top" align="left">Forward primer for cloning <italic>mlaC</italic> into pET28b including 6 codons for His, <italic>BspHI</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">MlaC_ Lw</td>
<td valign="top" align="left">GAGctcgagTTACTTGCCATTGCCCGCGGGCCCGGCCTGCAT</td>
<td valign="top" align="left">Reverse primer for cloning <italic>mlaC</italic> into pET28b, <italic>XhoI</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">PAO1-PA5548-Ctr</td>
<td valign="top" align="left">TTACCTGCGACGTTATCTGAAGC</td>
<td valign="top" align="left">Forward primer for amplification of the left flanking mini-Tn<italic>7</italic> region</td>
</tr>
<tr>
<td valign="top" align="left">PAO1-glmS-Ctrl1</td>
<td valign="top" align="left">GCTGAAGCTCAAGGAAATTTCC</td>
<td valign="top" align="left">Reverse primer for amplification of the right flanking mini-Tn<italic>7</italic> region</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="fnT2_1">
<label>a</label>
<p>Restriction site is shown in lower case letters.</p>
</fn>
<fn id="fnT2_2">
<label>b</label>
<p>The primers have been described previously (<xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Construction of fluorescently labelled strains</title>
<p>The fluorescently labelled <italic>S. maltophilia</italic> wild-type strain K279a::sfGFP was constructed previously with a mini-Tn<italic>7</italic> delivery system that has been optimized for work with bacteria of the family <italic>Xanthomonadaceae</italic> (<xref ref-type="bibr" rid="B58">Mamat et&#xa0;al., 2023</xref>). The same procedure using transfer of the mini-Tn<italic>7</italic> delivery plasmid pUC18T-mini-Tn<italic>7</italic>T-Gm-Pc-sfGFP to <italic>S. maltophilia</italic> K279a &#x394;<italic>mlaF-B</italic> by four-parental mating was applied herein to label the <italic>mla</italic> mutant strain with sfGFP. For the construction of <italic>P. aeruginosa</italic> PAO1::tdTomato, the plasmid pUC18T-mini-Tn<italic>7</italic>T-Gm-Pc-tdTomato was transferred to the <italic>P. aeruginosa</italic> PAO1 wild-type strain by conjugation, involving <italic>E. coli</italic> DH5&#x3b1;/pRK2013 (<xref ref-type="bibr" rid="B30">Figurski and Helinski, 1979</xref>) and <italic>E. coli</italic> SM10 &#x3bb;<italic>pir</italic>/pUX-BF13 as helper strains, <italic>E. coli</italic> DH5&#x3b1;/pUC18T-mini-Tn<italic>7</italic>T-Gm-Pc-tdTomato (<xref ref-type="bibr" rid="B58">Mamat et&#xa0;al., 2023</xref>) as the donor, and <italic>P. aeruginosa</italic> PAO1 as the recipient strain. The strains were grown overnight in LB media with kanamycin (30 &#xb5;g/mL) for <italic>E. coli</italic> DH5&#x3b1;/pRK2013, 100 &#xb5;g/mL of ampicillin for <italic>E. coli</italic> SM10 &#x3bb;<italic>pir</italic>/pUX-BF13, and ampicillin (100 &#xb5;g/mL) and gentamycin (15 &#xb5;g/mL) for <italic>E. coli</italic> DH5&#x3b1;/pUC18T-mini-Tn<italic>7</italic>T-Gm-Pc-tdTomato. The cells from 1 mL of each <italic>E. coli</italic> culture and 330 &#xb5;L of <italic>P. aeruginosa</italic> PAO1 were harvested by centrifugation. For preparation of the mating mixture, the cell pellets of all strains were pooled in 1 mL of LB medium, sedimented by centrifugation, resuspended in 100 &#xb5;L of super optimal broth (SOB) (0.5% yeast extract, 2% tryptone, 10 mM NaCl, 2.5 mM KCl, 20 mM MgSO<sub>4</sub>) and then spotted onto an SOB agar plate essentially as described elsewhere (<xref ref-type="bibr" rid="B8">Aubert et&#xa0;al., 2014</xref>). The <italic>P. aeruginosa</italic> PAO1 transconjugants were selected at 37&#xb0;C on Vogel-Bonner minimal medium (VBMM) (3 g/L trisodium citrate, 2 g/L citric acid, 10 g/L K<sub>2</sub>HPO<sub>4</sub>, 3.5 g/L NaNH<sub>4</sub>PO<sub>4</sub>&#xb7;4H<sub>2</sub>O, 1 mM MgSO<sub>4</sub>, 100 &#xb5;M CaCl<sub>2</sub>, pH 7.0) agar plates containing 30 &#xb5;g/mL of gentamycin (<xref ref-type="bibr" rid="B17">Choi and Schweizer, 2006</xref>). Chromosomal insertion of the mini-Tn<italic>7</italic> transposon downstream of the <italic>glmS</italic> gene for glutamine&#x2013;fructose-6-phosphate aminotransferase was verified by PCR, using the primer pairs PTn7R (<xref ref-type="bibr" rid="B17">Choi and Schweizer, 2006</xref>) and PAO1-glmS-Ctrl1, and PTn7L (<xref ref-type="bibr" rid="B17">Choi and Schweizer, 2006</xref>) and PAO1-PA5548-Ctr to amplify the flanking mini-Tn<italic>7</italic> regions (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>), respectively.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Growth curves and competition assays</title>
<p>To compare the growth of mutant strains with that of their parent strains, fresh overnight cultures were adjusted to an OD<sub>600nm</sub> of 0.01 with appropriate media, followed by transfer of 200&#x2009;&#x3bc;L of each diluted culture to each well of a conventional 96-well microtiter plate (triplicate samples). The plates were incubated for 24 hours in a Multiskan FC microplate photometer (Thermo Fisher Scientific) with constant circular shaking at 30&#xb0;C or 37&#xb0;C for bacterial growth, and the OD<sub>550nm</sub> was measured every 15&#x2009;min.</p>
<p>For growth competition assays on agar plates, overnight cultures of <italic>S. maltophilia</italic> were adjusted to OD<sub>600nm</sub> of 0.01 and spread onto LBA using a sterile cotton swab to prepare a bacterial lawn. Five microliters of logarithmic cultures of <italic>P. aeruginosa</italic> PAO1 were spotted onto the competitor lawns using a micropipette. Plates were incubated for 24 hours at 37&#xb0;C. For growth competition assays in liquid cultures, overnight cultures in 0.5 &#xd7; BHI medium were diluted to an OD<sub>600nm</sub> of 0.05 (&#x223c;5 &#xd7; 10<sup>8</sup> CFU/mL) and were inoculated simultaneously at an equal ratio (1:1 v/v). Samples were collected at 24 hours, serially diluted in PBS, and then seeded onto LBA with 60 &#xb5;g/mL chloramphenicol for <italic>P. aeruginosa</italic> PAO1 and LBA with 50 &#xb5;g/mL streptomycin for <italic>S. maltophilia</italic> K279a. The agar plates were incubated at 37&#xb0;C for 24 hours and the number of viable cells was determined.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Plating efficiency assay</title>
<p>For plating efficiency tests, strains were grown overnight in LB medium at 37&#xb0;C, serially diluted 10-fold, and then replica plated on LBA or MacConkey agar (MacConkey broth from Oxoid with 1.5% (w/v) agar). Plates were then incubated overnight at 37&#xb0;C.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Antimicrobial susceptibility testing</title>
<p>The minimum inhibitory concentration (MIC) of a broad spectrum of antibiotics was determined using the broth microdilution method in accordance with CLSI guidelines (<xref ref-type="bibr" rid="B19">CLSI, 2015</xref>) and EUCAST recommendations for colistin (<xref ref-type="bibr" rid="B82">The European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute, 2016</xref>). Briefly, MICs were determined in sterile 96-well plates by two-fold serial dilutions of the corresponding antibiotic in cation adjusted Mueller-Hinton broth (CAMHB). To prepare CAMHB, Mueller-Hinton Broth (MHB) from Oxoid (cat. No. CM0405) was supplemented with calcium and magnesium to final concentrations of 25 and 12.5 mg/L, respectively. First, two-fold serial dilutions of antibiotics were prepared in 100 &#x3bc;l of CAMHB in microtiter plate wells. Overnight cultures in CAMHB were diluted in the same media to contain an initial inoculum of 5 &#xd7; 10<sup>5</sup> cells/mL. Each well containing the corresponding two-fold serial antibiotic dilution was filled with 100 &#xb5;L of the cell suspension (final volume of 200 &#xb5;L/well). MIC plates were read after 20 hours of incubation at 37&#xb0;C without shaking. The MIC was determined to be the lowest concentration at which no bacterial growth occurred, as assessed by visual inspection and confirmed by adding 30 &#xb5;L of 0.01% resazurin to each well to determine cell viability. Susceptibility to the membrane-damaging agents EDTA (ethylenediaminetetraacetic acid) and SDS (sodium dodecyl sulfate) was also determined by the broth microdilution method using MHB.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>NPN outer membrane permeability assay</title>
<p>Uptake of 1-<italic>N</italic>-phenylnaphthylamine (NPN) was investigated as previously described (<xref ref-type="bibr" rid="B41">Helander and Mattila-Sandholm, 2000</xref>), with a few modifications (<xref ref-type="bibr" rid="B54">Loh et&#xa0;al., 1984</xref>; <xref ref-type="bibr" rid="B28">Fern&#xe1;ndez et&#xa0;al., 2012</xref>). Stock solutions of NPN at 50 mM and the uncoupler carbonyl cyanide <italic>m</italic>-chlorophenylhydrazone (CCCP) at 5 mM, both reagents purchased from Sigma-Aldrich, were prepared in advance in acetone. NPN was then diluted in 5 mM HEPES buffer (pH 7.2) to a concentration of 40 &#xb5;M to prepare a working solution. Bacterial overnight cultures were diluted 100-fold in LB medium with appropriate antibiotic and grown to mid-exponential phase (OD<sub>600nm</sub> of 0.6). Cells were harvested by centrifugation at room temperature and resuspended in 5 mM HEPES buffer (pH 7.2) supplemented with CCCP at 5 &#xb5;M (HEPES-CCCP buffer). The cell suspension (OD<sub>600nm</sub> = 0.5) was left at 23&#xb0;C for an hour before adding any reagent. The cell suspension (100 &#xb5;L), 40 &#xb5;M NPN working solution (50 &#xb5;L) and HEPES-CCCP buffer (50 &#xb5;L) were mixed in flat-bottomed black 96-well plates immediately before measuring the fluorescence (excitation, 340 nm; emission, 415 nm) in a Victor 3V 1420 multilabel plate reader (PerkinElmer<sup>&#xae;</sup>). To increase membrane permeability, 0.5 mM EDTA was added. Values were recorded up to 3 min to calculate NPN uptake kinetics. The results were expressed as relative fluorescence units (fluorescence value for the cell suspension with NPN, minus the corresponding value for the control), per triplicate samples, and two-way analysis of variance (ANOVA) with Bonferroni&#x2019;s multiple-comparison test was applied to the data (GraphPad Prism v 9.0; GraphPad Inc, San Diego, USA).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Bioassay for diffusible signal factor detection</title>
<p>DSF determination was performed using the reporter strain <italic>Xanthomonas campestris pv. campestris</italic> (<italic>Xcc</italic>) 8523 pL6engGUS as previously described (<xref ref-type="bibr" rid="B48">Huedo et&#xa0;al., 2015</xref>). The Xcc reporter strain was routinely grown in NYG medium (0.5% peptone, 0.3% yeast extract and 2% glycerol) supplemented with 10 &#x3bc;g/mL of tetracycline at 28&#xb0;C. Strains to be tested were pin inoculated onto NYG agar plates containing 80 &#x3bc;g/mL of 5-bromo-4-chloro-3-indolyl-&#x3b2;-<sc>d</sc>-glucopyranoside (X-Glu) and the DSF-reporter strain and incubated for 24 hours at 28&#xb0;C. The presence of a blue halo around the colony indicated DSF activity.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Congo red agar plate assay</title>
<p>Overnight cultures were streaked onto BHI agar containing 3% sucrose and 0.08% (wt/v) Congo red dye. Plates were incubated at 30&#xb0;C for 24 hours, and colonies were then examined for absorption of Congo red dye.</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Biofilm formation assays</title>
<p>To evaluate single-species biofilm formation under static conditions, overnight cultures of the strains were grown aerobically (200&#x2009;rpm) in 0.5&#x2009;&#xd7;&#x2009;BHI broth or modified BM2-glucose minimal medium at 37&#xb0;C, followed by dilution of each culture with the corresponding fresh medium to an OD<sub>600nm</sub> of 0.05. Only the overnight cultures of the complemented strain carrying the plasmid pBBR1MCS1-<italic>mlaF-B</italic> were supplemented with 60 &#xb5;g/mL of chloramphenicol. Sterile, untreated 96-well flat-bottom microtiter plates were then inoculated with the fresh bacterial suspensions (200&#x2009;&#x3bc;L per well) and incubated at 30&#xb0;C for 24&#x2009;hours in a humidified atmosphere. Quantification of the biofilm biomass was performed by crystal violet (CV) staining as described previously (<xref ref-type="bibr" rid="B94">Yero et&#xa0;al., 2020</xref>). The amount of biofilm was quantified by measuring the OD<sub>550</sub> of dissolved CV using a microplate reader (Multiskan FC microplate photometer, Thermo Fisher Scientific).</p>
<p>Mixed biofilms of <italic>S. maltophilia</italic> and <italic>P. aeruginosa</italic> strains were investigated with sfGFP- or tdTomato-labelled cells, respectively, in ibiTreat &#xb5;-Slide 8 well plates (Ibidi, Cat.No: 80826). To grow mixed biofilms of fluorescently tagged <italic>S. maltophilia</italic> and <italic>P. aeruginosa</italic> strains, preparation of the samples included overnight pre-cultures of the strains grown with agitation at 37&#xb0;C in 0.5 &#xd7; BHI medium and containing 60 &#xb5;g/mL of chloramphenicol for the complemented mutant strain. The next day, the OD<sub>600nm</sub> was adjusted to 0.05 for the initial inocula in 0.5 &#xd7; BHI medium at 30&#xb0;C, and 200 &#xb5;L of each strain (in duplicate) were inoculated into 8-well chambers and incubated at 30&#xb0;C in a humidified atmosphere. Every 12 hours, the medium was aspirated from each chamber and fresh medium was added, up to a total incubation time of 72 hours. Prior to observation under the microscope, all excess medium was aspirated to image the biofilm. Imaging was performed with a TCS SP5 inverse confocal laser-scanning microscope (Leica Microsystems, Mannheim, Germany) equipped with a Leica 63x/NA 1.40 HCX Plan Apochromat CS oil immersion objective. The sfGFP protein was excited with 488 nm laser light, and fluorescence emission was detected between 495 and 550 nm. The excitation wavelength of laser light was 561 nm for tdTomato and emission of its fluorescence was detected between 580 and 630 nm. The fluorescent signal from a minimum of three fields per chamber was collected (50 z-stacks) for processing. The images were analyzed with LAS AF software (version 2.73) and three-dimensional biofilm images were generated from confocal image stacks using the <italic>daime</italic> computer program (<xref ref-type="bibr" rid="B21">Daims et&#xa0;al., 2006</xref>). Images were split into individual color channels for biovolume quantification using the <italic>daime</italic> software. Image acquisition and processing was carried out at the core facility Fluorescence Cytometry of the Research Center Borstel (Borstel, Germany). ANOVA with Bonferroni&#x2019;s multiple-comparison test was applied to the data from all biofilm experiments using GraphPad Prism v 9.0.</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Electron microscopy of bacterial cells</title>
<p>The visualization of <italic>S. maltophilia</italic> cells was performed on a Scanning Electron Microscope (SEM) LEO SEM 1525 (Zeiss, Germany) at 5 kV at the Hamburg Zoological Institute (Hamburg, Germany). Overnight cultures of each strain were prepared in 5 mL of LB medium with or without a sub-inhibitory concentration of 0.5 mM EDTA. The suspensions were centrifuged at 13,000 rpm for 2 min, and the cell sediments were resuspended in 500 &#xb5;L of sterile PBS. Samples were fixed in 1% paraformaldehyde and gradually dehydrated in increasing concentrations of ethanol. The dehydration step was completed by drying the pellets at the critical point with a Balzers CPD 030 Critical Point Dryer instrument. Prior to visualization, the samples were coated with gold particles using an SCD 050 Sputter Coater (Bal-Tec, United States).</p>
<p>Visualization of internal structures of the different strains of <italic>S. maltophilia</italic> was carried out using the transmission electron microscope (TEM) Biotwin CM120 (Philips, Netherlands) operating at 120 kV in the facilities of the Biocenter Klein Flottbek of the University of Hamburg (Germany). Overnight cultures were prepared under the same conditions as for SEM. Cells were fixed overnight with 2.5% glutaraldehyde and post-fixed with 1% osmium tetraoxide for 2 hours. Prior to observation, the cells were dehydrated in ethanol gradients. Ultrathin sections were obtained using a UC7 ultramicrotome (Leica Microsystems) and deposited on a nickel-coated grid and counterstained with uranyl acetate and lead citrate. The images obtained with the Gatan MSC 794 camera were recovered with the built-in Digital Micrograph software.</p>
</sec>
<sec id="s2_12">
<label>2.12</label>
<title>Recombinant MlaC expression and purification</title>
<p>To produce N-terminally His-tagged MlaC (Smlt4573) protein in <italic>E. coli</italic> BL21(DE3)pLysS, the coding region was cloned into the <italic>Nco</italic>I/<italic>Xho</italic>I sites of pET28b using standard techniques and primers MlaC_His_Up and MlaC_Lw (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). Since MlaC is naturally located in the periplasm, the signal sequence was removed from the coding sequence of the recombinant protein. The cells of an overnight culture of <italic>E. coli</italic> BL21(DE3)pLysS containing the pET28b-H6-MlaC plasmid were diluted 1:100 in 2 L of pre-warmed LB and grown to mid-exponential phase (OD<sub>600nm</sub> = 0.6). Isopropyl-&#xdf;-<sc>d</sc>-thiogalactopyranoside (IPTG) was added to the culture at a final concentration of 1 mM for protein expression induction. After four hours, cells were harvested (OD<sub>600nm</sub> = 3.5) and washed twice with sterile PBS. In order to verify the presence of the MlaC protein in the soluble fraction, the cell pellet was resuspended in lysis buffer (5 mM imidazole, 0.5 M NaCl, 0.1% Triton X-100, 5% glycerol, 20 mM Tris-HCl, pH 7.9), lysed by sonication in an ice bath, and separated by 12% SDS-PAGE. Protein purification was performed by the Protein Production Platform (PPP) of Nanbiosis facilities at the Institute of Biotechnology and Biomedicine of the Universitat Aut&#xf2;noma de Barcelona (UAB, Spain). Briefly, cells were disrupted by sonication in lysis buffer containing 4 &#xb5;g/mL lysozyme, 8 &#xb5;g/mL DNase and 2 mM MgCl<sub>2</sub>. Protein was purified from the soluble fraction by immobilized metal affinity chromatography (IMAC) on a HisTrap HP 5 mL (GE, 17-5248-01) column with washing buffer (40 mM imidazole, 0.33 M NaCl, 13.3 mM Tris-HCl, pH 7.9) and elution buffer (125 mM imidazole, 62.5 mM NaCl, 2.5 mM Tris-HCl, pH 7.9). Eluted protein was immediately dialyzed against 50 mM Na<sub>2</sub>HPO<sub>4</sub> (pH 7.0) to remove the imidazole.</p>
</sec>
<sec id="s2_13">
<label>2.13</label>
<title>Delipidation of purified MlaC protein</title>
<p>Recombinant MlaC protein produced in <italic>E. coli</italic> was delipidated using an HPLC system and a C18 column (Phenomenex Jupiter 5U C18 300A) in 0.1% TFA. Protein was eluted from the column with a gradient of acetonitrile in 0.1% TFA.</p>
</sec>
<sec id="s2_14">
<label>2.14</label>
<title>Mass spectrometry and <italic>E. coli</italic> phospholipid identification</title>
<p>Protein identity was confirmed by peptide mass fingerprinting using matrix-assisted laser desorption ionization&#x2013;time of flight mass spectrometry (MALDI-TOF MS) at the Proteomics Laboratory of the Consejo Superior de Investigaciones Cient&#xed;ficas and UAB. Analysis of MlaC-bound PLs was done under denaturing conditions by MALDI-TOF MS in the negative ion mode with 9-aminoacridine as matrix. The identification of <italic>E. coli</italic> PLs present in the sample was done according to <xref ref-type="bibr" rid="B68">Oursel et&#xa0;al. (2007)</xref> and <xref ref-type="bibr" rid="B33">Gidden et&#xa0;al. (2009)</xref>, using Lipidomics Gateway (<ext-link ext-link-type="uri" xlink:href="http://www.lipidmaps.org">http://www.lipidmaps.org</ext-link>) based on the m/z values of MS spectra.</p>
</sec>
<sec id="s2_15">
<label>2.15</label>
<title>Biophysical characterization of phospholipid binding to MlaC protein</title>
<p>The binding of phosphatidylethanolamines PE14/14 and PE16/16 to MlaC was first evaluated by nano Differential Scanning Fluorimetry (nanoDSF), which determines the melting temperature of the protein in the presence and absence of compound. The reaction buffer was optimized to 50 mM MOPS pH 7.0, 100 mM NaCl and 0.05% Tween, for a final reaction volume of 10 &#x3bc;l; final protein and compound concentrations were 5 &#x3bc;M and 100 &#x3bc;M, respectively, and DMSO concentration was 1%; the reaction temperature was 20-95&#xb0;C, with a heating rate of 1&#xb0;C min<sup>-1</sup>. Binding and corresponding K<sub>d</sub> values were then evaluated by MicroScale Thermophoresis (MST), which measures protein movement along a temperature gradient in the presence and absence of compound. The reaction buffer was as for nanoDSF; final dye and protein concentrations were 5 nM and 100 nM, respectively; MST excitation power was 20%. Both assays were performed by Proteros Biostructures GmbH (Germany).</p>
</sec>
<sec id="s2_16">
<label>2.16</label>
<title>Bioinformatics analysis</title>
<p>
<italic>S. maltophilia</italic> K279a homologues of <italic>P. aeruginosa</italic> PAO1 genes coding for Ttg2ABCDE (PA4452-PA4456) or VacJ (PA2800) and <italic>E. coli</italic> K-12 substr. MG1655 genes encoding MlaFEDCB (b3195- b3191) or MlaA (b2346) were identified as follows. Protein sequences were first analyzed using BLAST, PSI-BLAST and CDD within NCBI (<ext-link ext-link-type="uri" xlink:href="http://ncbi.nlm.nih.gov/">http://ncbi.nlm.nih.gov/</ext-link>). Orthologous sequences in other species were searched using BLASTp and initially aligned with Clustal Omega (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/Tools/msa/clustalo/">https://www.ebi.ac.uk/Tools/msa/clustalo/</ext-link>). Promoter prediction was done by means of PRODORIC database (<xref ref-type="bibr" rid="B24">Dudek and Jahn, 2022</xref>). Operon organization was inferred from the BioCyc data collection (<xref ref-type="bibr" rid="B15">Caspi et&#xa0;al., 2016</xref>) and MicrobesOnline database (<xref ref-type="bibr" rid="B6">Alm et&#xa0;al., 2005</xref>). Transcription units were identified by mapping reads from previously published RNA-seq experiment (GEO GSE206442) (<xref ref-type="bibr" rid="B20">Coves et&#xa0;al., 2023</xref>) on the K279a chromosome and visualized by the Artemis genome browser (<xref ref-type="bibr" rid="B76">Rutherford et&#xa0;al., 2000</xref>).</p>
<p>Protein structures of MlaC orthologues from <italic>P. aeruginosa</italic> (6HSY) (<xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>), <italic>E. coli</italic> (5UWA) (<xref ref-type="bibr" rid="B25">Ekiert et&#xa0;al., 2017</xref>) and <italic>Ralstonia solanacearum</italic> (2QGU) were obtained from the RCSB PDB database (<ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/">https://www.rcsb.org/</ext-link>). For structural comparisons, all selected structures are lipid-bound and hydrogen atoms were removed from the 6HSY structure. Multiple sequence alignment was constructed using hmmalign tool from the HMMER v3.3.2 package (<xref ref-type="bibr" rid="B64">Mistry et&#xa0;al., 2013</xref>) using Pfam PF05494.15 profile (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/interpro/">https://www.ebi.ac.uk/interpro/</ext-link>) and presented with Jalview (<xref ref-type="bibr" rid="B90">Waterhouse et&#xa0;al., 2009</xref>). DeepMind&#x2019;s AlphaFold (<xref ref-type="bibr" rid="B51">Jumper et&#xa0;al., 2021</xref>) version 2.2.4, locally installed and running in a Docker container, was used to model the Smlt4673 protein from residue A28 onward. AlphaFold was obtained from <ext-link ext-link-type="uri" xlink:href="https://github.com/deepmind/alphafold">https://github.com/deepmind/alphafold</ext-link>. The script provided by the developers was used to download all required databases (software and databases were downloaded on October 18th, 2022). The AlphaFold script was run with default parameters using the &#x201c;monomer_ptm&#x201d; model, full databases and multiple sequence alignments constructed using all templates available at the download date. 3D structure supersposition was carried out using DaliLite.v5.1 (<xref ref-type="bibr" rid="B43">Holm, 2019</xref>) and cavities were analyzed with the web server CASTp (<xref ref-type="bibr" rid="B85">Tian et&#xa0;al., 2018</xref>). PyMOL v2.4.2 was used for protein structure visual analysis and figure preparation (<xref ref-type="bibr" rid="B83">The PyMOL Molecular Graphics System, Version 2.4.2,  2022</xref>).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>The <italic>mla</italic> operon in <italic>S. maltophilia</italic>
</title>
<p>We first examined the genomic organization of the <italic>mla</italic> genes (Smlt4670-Smlt4675) in the <italic>S. maltophilia</italic> K279a reference genome and compared it to that previously found in other Pseudomonadota (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A</bold>
</xref>). BioCyc predicted that the <italic>mla</italic> operon is divided into two distinct transcription units: <italic>smlt4670</italic> (<italic>mlaF</italic>) and <italic>smlt4671</italic> (<italic>mlaE</italic>), and <italic>smlt4672</italic> (<italic>mlaD</italic>) to <italic>smlt4675</italic> (<italic>mlaA</italic>). However, several lines of evidence suggest that all six genes belong to the same transcription unit: (i) the <italic>mla</italic> genes are oriented in the same direction on the chromosome including a maximum intergenic region of 59 bp between them (<italic>mlaE</italic> to <italic>mlaD</italic>), (ii) the lack of canonical promoters between <italic>mlaF</italic> and <italic>mlaA</italic> as predicted by the PRODORIC database, (iii) the existence of a complete <italic>mla</italic> operon with similar organization in other species, such as <italic>Neisseria gonorrhoeae</italic> (<xref ref-type="bibr" rid="B9">Baarda et&#xa0;al., 2019</xref>), (iv) transcriptomic studies for <italic>S. maltophilia</italic> K279a in different growth phases revealed a common deregulation of the expression of these six genes (<xref ref-type="bibr" rid="B20">Coves et&#xa0;al., 2023</xref>), and (v) mapping of reads indicated the existence of a single transcription unit, although there appear to be internal promoters upstream to some CDS such as <italic>smlt4674</italic> (<italic>mlaB</italic>) and <italic>smlt4675</italic> (<italic>mlaA</italic>) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1B</bold>
</xref>). Taken together, these observations strongly suggest the organization of the genes of the Mla system in a single polycistronic operon in <italic>S. maltophilia</italic>.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Sequence and structural analysis of <italic>S. maltophilia</italic> MlaC</title>
<p>The MlaC (Smlt4673) protein of <italic>S. maltophilia</italic> is the soluble periplasmic PL-binding component of the Mla system. First, the primary amino acid sequence of Smlt4673 was compared with that of orthologous proteins from <italic>P. aeruginosa</italic>, <italic>E. coli</italic>, and <italic>R. solanacearum</italic>, whose 3D structures have already been solved (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2</bold>
</xref>). Despite low sequence identity between the MlaC protein of <italic>S. maltophilia</italic> and other organisms (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>2</bold>
</xref>), the protein structure is expected to be highly conserved as shown for other species (<xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>). The AlphaFold prediction for the 3D structure of Smlt4673 (UniProt accession B2FP85) yielded five models with pLDDT scores between 91.9 and 89.52 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>), showing great confidence in the central zone of the sequence, which aligns perfectly with the Hidden Markov Model profile that defines the Pfam family MlaC (PF05494), leaving the areas with less confidence at the extremes. A superposition of all models over the best-ranking one resulted in root-mean-square deviation (RMSD) values between 0.9&#xc5; and 1.3&#xc5;, indicating a high similarity between them (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>). The C-terminal region was predicted as unstructured (<xref ref-type="bibr" rid="B87">Tunyasuvunakool et&#xa0;al., 2021</xref>), likely due to the presence of glycine and proline residues (<xref ref-type="bibr" rid="B50">Hutchinson and Thornton, 1994</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>AlphaFold prediction for the 3D structure of MlaC (Smlt4673) of <italic>S. maltophilia</italic> from residue A28 to the last protein residue. <bold>(A)</bold> The five models generated by AlphaFold superimposed to the top-ranked model and colored according to the per-residue pLDDT score (Model Confidence). <bold>(B)</bold> CASTp-predicted ligand-binding cavity for the Smlt4673 AlphaFold models for which the cavity volume is highest (upper figure) and lowest (lower figure).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1346565-g001.tif"/>
</fig>
<p>Superposition of the best-scoring model for Smlt4673 with the 3D structures of orthologous proteins whose amino acid sequences are aligned in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2</bold>
</xref> confirmed that structure is conserved among members of this protein family (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3</bold>
</xref>). As shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>, the most similar structure is that of <italic>P. aeruginosa</italic>, with an RMSD of 2.3&#xc5;, 176 out of 190 superposed amino acids, and a sequence identity of 25%. Note that all structures used for this comparison were solved in complex with a lipid ligand in its hydrophobic pocket. Finally, an analysis of the ligand-binding cavity in the five AlphaFold models revealed volumes between 1777.2 and 2751.6 &#xc5;<sup>3</sup> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>), which were compared to the values for the already known ortholog structures in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref> (see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4</bold>
</xref> for a surface representation of the cavity in orthologous structures). According to the models, the Smlt473 cavity would be smaller than that of the MlaC ortholog of <italic>P. aeruginosa</italic>, but larger than those in the other MlaC proteins used for comparison (<italic>E. coli</italic> and <italic>R. solanacearum</italic>). Amino acids and secondary structures that could contribute to the size and flexibility of the cavity and ligand binding are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;3</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>5</bold>
</xref>.</p>
<p>The original description of the first structure solved for a MlaC protein, from <italic>E. coli</italic> (PDB 5UWA) (<xref ref-type="bibr" rid="B25">Ekiert et&#xa0;al., 2017</xref>), identified its fold with a transport protein domain known as NTF2. In a later study, the presence of a second domain, similar to the small helical domain of AAA+ ATPases, was identified and investigated (<xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>). It was suggested that this domain may be responsible for the increase in cavity volume of MlaC proteins relative to other proteins with NTF2-type domains. In particular, the capacity of different MlaC orthologs to simultaneously transport two PLs was evaluated. This capacity was attributed to a bend caused by a glycine residue in the C-terminal helix and an adjacent tryptophan (G195 and W196 in 6HSY). The sequence of MlaC from <italic>S. maltophilia</italic> does not have either of these amino acids at these positions (E205 and L206) and the generated model displays a straight helix with no bend at this position. In fact, MlaC from <italic>S. maltophilia</italic> has a sequence very similar to that of <italic>E. coli</italic> (Q196 and L197), whose structure also shows a straight helix. However, the high presence of glycine residues down the sequence (G209, G214, P215, G217, G219) is likely to provide high flexibility to the region (<xref ref-type="bibr" rid="B50">Hutchinson and Thornton, 1994</xref>), as predicted by AlphaFold. This could translate in a capacity to accommodate one or two substrates, as shown for the <italic>P. aeruginosa</italic> protein (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>3</bold>
</xref>).</p>
<p>Analyzing the superposition of the known structures of the MlaC family, one recognizes the persistent presence of bulky residues inside the small helical AAA-like domain. In all but the 6HSY structure, the aromatic side chain of the residue superposed to F190 in Smlt4673 AlphaFold model (i.e., F181 in 2QGU and W181 in 5UWA) is occupying the same space. In <italic>P. aeruginosa</italic>, thanks to the bend produced by G195, this space is occupied by W196, which displaces F178 (the residue superposed to Smlt4673 F190) towards the interior of the domain, increasing the number of atoms housed there. Most likely, this causes the separation between the helices that form this domain in 6HSY, increasing the volume of the cavity in the NTF2 domain and enabling the binding of a second PL. Another position occupied in all cases by an aromatic residue except in 2QGU is Smlt4673 F104, which most likely would be interacting with the previously mentioned aromatic residue (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>4A, B</bold>
</xref>). On the other hand, all the structures studied show the presence of two bulky residues facing each other, marking the beginning of this domain and interacting with the PL (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;5C</bold>
</xref>).</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Phospholipid cargo in protein MlaC of <italic>S. maltophilia</italic>
</title>
<p>Denaturing mass spectrometry was used to determine the lipids that were specifically bound to recombinant MlaC from <italic>S. maltophilia</italic> produced in the cytoplasm of <italic>E. coli</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Although this is clearly not the natural environment of the protein (i.e., the periplasmic space of <italic>S. maltophilia</italic>), several types of PLs were identified by the assay. A delipidated variant of the protein was used as a control. PLs bound by <italic>S. maltophilia</italic> MlaC belonged primarily to the phosphatidylglycerol (PG) and phosphatidylethanolamine (PE) types (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>), as previously described for other MlaC proteins. Lipid species with <italic>m/z</italic> of 719.5, 733.5 and 747.5 were found to be the most abundant under the assayed conditions (MALDI-TOF MS in the negative mode).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>MlaC of <italic>S. maltophilia</italic> is a promiscuous PL-binding protein. <bold>(A)</bold> Determination of PL species co-purified with MlaC expressed in <italic>E. coli</italic> before (upper panel) and after (lower panel) delipidation of the protein by HPLC. MALDI-TOF/TOF mass spectra under denaturing conditions in negative ion mode. <bold>(B)</bold> Relationship of m/z values to the most probable PL species in <italic>E. coli</italic>. Abundant [M-H]&#x2212; ions were observed for two glycerophospholipid classes: phosphatidylglycerols (PGs) and phosphatidylethanolamines (PEs). <bold>(C)</bold> T<sub>m</sub> shift of MlaC protein with PLs, compared with protein control in 1% DMSO, as determined by nanoDSF. PE14/14 (PE C14:0/C14:0) shows a shift in the edge of significance (red lines at +/- 0.5&#xb0;C from control). <bold>(D, E)</bold> K<sub>d</sub> determination with PE14/14 and PE16/16 (PE C16:0/C16:0) by MST confirmed potential binding of PE14/14, with no evidence of binding for PE16/16, as also observed with nanoDSF. The normalized fluorescence (Fnorm%) is indicated in the y-axis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1346565-g002.tif"/>
</fig>
<p>
<italic>In vitro</italic> evaluation of the binding of delipidated MlaC to free PLs using microscale thermophoresis (MST) and nanoDSF provided the protein&#x2019;s binding affinity for the specific PE variants C14:0/C14:0 and C16:0/C16:0 (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C&#x2013;E</bold>
</xref>). For C16:0/C16:0, no binding to MlaC was observed in either assay. For C14:0/C14:0, both assays showed potential binding to MlaC, albeit with a low-affinity K<sub>d</sub> of 795 &#xb5;M (MST).</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>The Mla system of <italic>S. maltophilia</italic> contributes to the maintenance of the OM barrier</title>
<p>We investigated the effects of the Mla system on OM permeability by analyzing two K279a mutant strains, one lacking the components of the <italic>mla</italic> operon except for <italic>mlaA</italic> (&#x394;<italic>mlaF-B</italic>) and the other lacking the <italic>mlaA</italic> gene (&#x394;<italic>mlaA</italic>). First, we showed that none of the mutants exhibited a growth defect under different standard laboratory conditions (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;6</bold>
</xref>). In order to confirm an OM-barrier defect due to an incomplete Mla system, the sensitivities of the wild-type, mutants and their complemented strains to OM stressors, such as the chelating agent EDTA, SDS, and bile salts, were measured. The mutants were fourfold more susceptible to EDTA (MIC&#x2009;=&#x2009;0.78&#x2009;mM) than the parental wild-type strain (MIC&#x2009;=&#x2009;3.125&#x2009;mM). However, no difference was observed between the mutant and wild-type cells in their susceptibility to SDS, with an MIC value of 0.04% for all strains (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). On the other hand, plating efficiency assays in the presence of bile salts (MacConkey) showed that growth of cells lacking the Mla system was partially impaired in comparison with wild-type and complemented strains (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Antimicrobial susceptibility profile of <italic>S. maltophilia</italic> mutants with defects in the Mla system and complemented strains.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="left">Antimicrobial agent</th>
<th valign="middle" colspan="6" align="center">Minimum inhibitory concentration (MIC)<xref ref-type="table-fn" rid="fnT3_1">
<sup>a</sup>
</xref>
</th>
</tr>
<tr>
<th valign="middle" align="center">K279a/pBBR1MCS1</th>
<th valign="middle" align="center">&#x394;<italic>mlaF-B</italic>/pBBR1MCS1</th>
<th valign="middle" align="center">&#x394;<italic>mlaF-B</italic>/p<italic>mlaF-B</italic>
</th>
<th valign="middle" align="center">K279a/pBBR1-BAD</th>
<th valign="middle" align="center">&#x394;<italic>mlaA</italic>/pBBR1-BAD</th>
<th valign="middle" align="center">&#x394;<italic>mlaA</italic>/p<italic>mlaA</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="middle" colspan="7" align="left">Sulfonamides</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Trimethoprim-sulphamethoxazole</td>
<td valign="middle" align="center">0.25</td>
<td valign="middle" align="center">0.25</td>
<td valign="middle" align="center">0.25</td>
<td valign="middle" align="center">0.25</td>
<td valign="middle" align="center">0.25</td>
<td valign="middle" align="center">0.25</td>
</tr>
<tr>
<th valign="middle" colspan="7" align="left">Polypeptides</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Colistin</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">
<bold>1</bold>
</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">
<bold>1</bold>
</td>
<td valign="middle" align="center">2</td>
</tr>
<tr>
<th valign="middle" colspan="7" align="left">Carbapenems (beta-lactam)</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Imipenem</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Meropenem</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
</tr>
<tr>
<th valign="middle" colspan="7" align="left">Cephalosporins (beta-lactam)</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Ceftazidime</td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">2</td>
<td valign="middle" align="center">2</td>
</tr>
<tr>
<th valign="middle" colspan="7" align="left">Penicillins (beta-lactam)</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Piperacillin-tazobactam</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Ticarcillin-clavulanic</td>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<th valign="middle" colspan="7" align="left">Aminoglycosides</th>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Tobramycin</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Amikacin</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Streptomycin</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
</tr>
<tr>
<th valign="middle" colspan="7" align="left">Chloramphenicol</th>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Chloramphenicol</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="center">128</td>
</tr>
<tr>
<th valign="middle" colspan="7" align="left">Tetracyclines</th>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Tetracycline</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
<td valign="middle" align="center">16</td>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Minocycline</td>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">
<bold>0.25</bold>
</td>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">1</td>
<td valign="middle" align="center">
<bold>0.25</bold>
</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Tigecycline</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
</tr>
<tr>
<th valign="middle" colspan="7" align="left">Fluoroquinolones</th>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Ciprofloxacin</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
<td valign="middle" align="center">8</td>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Levofloxacin</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Ofloxacin</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">4</td>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;Norfloxacin</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
<td valign="middle" align="center">32</td>
</tr>
<tr>
<th valign="middle" colspan="7" align="left">Other membrane-damaging agents</th>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;EDTA (in mM)</td>
<td valign="middle" align="center">3.125</td>
<td valign="middle" align="center">
<bold>0.78</bold>
</td>
<td valign="middle" align="center">3.125</td>
<td valign="middle" align="center">3.125</td>
<td valign="middle" align="center">
<bold>0.78</bold>
</td>
<td valign="middle" align="center">3.125</td>
</tr>
<tr>
<td valign="middle" align="left">&#xa0;SDS (in %)</td>
<td valign="middle" align="center">0.04</td>
<td valign="middle" align="center">0.04</td>
<td valign="middle" align="center">0.04</td>
<td valign="middle" align="center">0.04</td>
<td valign="middle" align="center">0.04</td>
<td valign="middle" align="center">0.04</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="fnT3_1">
<label>a</label>
<p>Minimum inhibitory concentration (MIC) determined by the broth microdilution method. The MIC is expressed in &#x3bc;g/mL, except for the EDTA and SDS agents. MICs were confirmed by two or three independent replicates and MIC differences greater than 2-fold with respect to the wild type strain were considered significant (indicated in bold). Complementation plasmids pBBR1MCS1-mlaF-B and pBBR1-BAD-Cm-mlaA are indicated as p<italic>mlaF-B</italic> and p<italic>mlaA</italic> respectively. For the MIC of EDTA and SDS, the wild type and mutant strains were not transformed with the empty vectors.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>The Mla system is required to maintain the homeostasis of the OM barrier. <bold>(A)</bold> Plating efficiency assay on MacConkey and LB agar plates. The ten-fold dilutions are indicated above each plate. K279a &#x394;<italic>mlaF-B</italic> and &#x394;<italic>mlaA</italic> mutants were more sensitive to bile salts. Complementation of each mutant restored the wild-type phenotype. Complementation plasmids pBBR1MCS1-<italic>mlaF-B</italic> and pBBR1-BAD-Cm-<italic>mlaA</italic> are indicated as p<italic>mlaF-B</italic> and p<italic>mlaA</italic> respectively. <bold>(B)</bold> NPN uptake, represented by the increase in fluorescence compared to cells not treated with NPN, without any supplementation. &#x394;<italic>mlaF-B</italic> showed increased cell permeability, which was partially restored by complementation. <bold>(C)</bold> NPN uptake assay in the presence of 0.5 mM EDTA. Asterisks represent 2-way ANOVA with <italic>post hoc</italic> Bonferroni test results for each time point versus the wild-type strain (<italic>P</italic>&lt;0.05).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1346565-g003.tif"/>
</fig>
<p>To investigate whether the deletion of components of the Mla system affects antibiotic resistance, the susceptibility of all strains to a broad spectrum of antibiotics was analyzed. As shown in <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>, both the <italic>mlaF-B</italic> and <italic>mlaA</italic> mutants showed increased susceptibility to colistin and minocycline among all antibiotics tested. The complemented strains showed restored MIC values. However, the sensitivity to the rest of the antibiotics remained unchanged. After these results and the evidence that both mutants showed the same susceptibility phenotypes, we decided to proceed with the mutant strain &#x394;<italic>mlaF-B</italic>.</p>
<p>The uptake rate of 1-<italic>N</italic>-phenylnapthylamine (NPN) was also measured. The NPN probe fluoresces strongly in PL environments but only weakly in aqueous environments, and a damaged OM should be more permeable to hydrophobic substances such as NPN. The increase in fluorescence levels was significantly higher in the &#x394;<italic>mlaF-B</italic> strain (<italic>P</italic>&lt;0.05) compared to the parental wild-type strain in the presence of 10 &#xb5;M NPN (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>), indicating a compromised integrity of the OM, partially restored by <italic>in trans</italic> complementation of &#x394;<italic>mlaF-B</italic> with pBBR1MCS1-<italic>mlaF-B</italic>. To demonstrate that the <italic>mla</italic>-defective strain was more sensitive to external stressors, EDTA was added at a subinhibitory concentration of 0.5 mM, which resulted in more pronounced differences when comparing the wild-type strain and the <italic>mla</italic> mutant (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). EDTA at this concentration did not affect the growth of the strains used in the assay (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;6</bold>
</xref>).</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>The absence of the Mla system affects the cell morphology of <italic>S. maltophilia</italic> in the presence of EDTA</title>
<p>To further investigate the effects that the mutation in the Mla system could have on <italic>S. maltophilia</italic> cells, we examined morphological changes in cell structure using electron microscopy. In a first step, samples from cell cultures of the wild-type strain, the mutant &#x394;<italic>mlaF-B</italic> and the complemented strain were examined by scanning electron microscopy (SEM). Under normal culture conditions, i.e., without addition of the chelating agent EDTA, the cells exhibited normal morphology with the characteristic rod-like shape of an <italic>S. maltophilia</italic> bacterium (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Despite a defective Mla system, no obvious morphological or structural differences were observed in &#x394;<italic>mlaF-B</italic> cells in the absence of EDTA (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>), suggesting that either the loss of components of the Mla system is not critical for maintaining the structural integrity of the membrane or that other systems are involved in compensating for this deficiency. Previous studies had also shown that cell structure was not affected in MlaA mutants of <italic>N. gonorrhoeae</italic> (<xref ref-type="bibr" rid="B9">Baarda et&#xa0;al., 2019</xref>) and <italic>Haemophilus influenzae</italic> (<xref ref-type="bibr" rid="B29">Fern&#xe1;ndez-Calvet et&#xa0;al., 2018</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Cells with deleted Mla components showed an altered cell morphology in the presence of EDTA. SEM analysis of bacterial cells without EDTA treatment <bold>(A)</bold> or treated with 0.5 mM EDTA <bold>(B)</bold>. Putative bacterial ghost cells are indicated by white arrowheads. Empty cell envelopes without cytoplasmic and nuclear contents as shown by TEM and marked with black arrowheads <bold>(C, D)</bold>. The scale bars in panels <bold>(A, B)</bold> represent 1 &#xb5;m, and the scale bars in panels <bold>(C, D)</bold> correspond to 0.2 &#xb5;m and 0.5 &#xb5;m, respectively. Complementation plasmid pBBR1MCS1-<italic>mlaF-B</italic> is indicated as p<italic>mlaF-B</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1346565-g004.tif"/>
</fig>
<p>In contrast, after treatment with EDTA at the subinhibitory concentration of 0.5 mM, mutant cells showed important morphological disorders. The &#x394;<italic>mlaF-B</italic> cells adopted a more spherical shape with smaller size in the presence of EDTA, indicating perturbations in the structural integrity of the cell envelope (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). The detrimental effects on the integrity of the bacterial cell envelope were further confirmed by the detection of bacterial ghost cells with irregular shapes in SEM and TEM (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4B&#x2013;D</bold>
</xref>), with the TEM images showing in particular empty cell envelopes devoid of cytoplasmic and nuclear contents (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4C, D</bold>
</xref>). Although the observed characteristics of the mutant strain upon contact with 0.5 mM EDTA indicated a decrease in cell viability, no effect of this concentration on the growth rate of the mutant strain could be detected (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;6</bold>
</xref>).</p>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Impaired biofilm formation by the Mla system mutant both in mono- and co-culture with <italic>P. aeruginosa</italic>
</title>
<p>We studied biofilm formation in microtiter plate under static conditions using K279a wild-type, mutant, and complemented strains grown in 0.5 &#xd7; BHI or a modified BM2-glucose minimal medium (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). The amount of biofilm formed by the &#x394;<italic>mlaF-B</italic> mutant was lower than that of the wild-type strain in the presence of EDTA (0.5 mM), but only when the cells were grown in minimal medium (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). EDTA at this concentration did not affect the planktonic growth of the strains under the same conditions used for biofilm formation (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;6</bold>
</xref>). To confirm the unique role of EDTA in biofilm reduction in the mutant strain, we also showed that production of both exopolysaccharide and the quorum sensing signal DSF (diffusible signal factor) were not affected in this strain (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;7</bold>
</xref>). In <italic>S. maltophilia</italic>, exopolysaccharide biosynthetic genes are necessary for biofilm production (<xref ref-type="bibr" rid="B46">Huang et&#xa0;al., 2006</xref>) and DSF positively regulates biofilm formation (<xref ref-type="bibr" rid="B3">Alcaraz et&#xa0;al., 2019</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Biofilm formation is reduced in the K279a &#x394;<italic>mlaF-B</italic> mutant when grown in modified BM2 minimal media. Cells were grown in a polystyrene microtiter plate in BM2-glucose minimal medium supplemented with casamino acids (CAA) or 0.5 &#xd7; BHI at 30&#xb0;C and without and with 0.5 mM EDTA. The amount of each biofilm was quantified by crystal violet staining (OD<sub>550</sub> value) after 24 hours of incubation under static conditions. Complementation plasmid pBBR1MCS1-<italic>mlaF-B</italic> is indicated as p<italic>mlaF-B</italic>. Data are means &#xb1; SD (n = 6). Two-way ANOVA with <italic>post hoc</italic> Bonferroni&#x2019;s multiple comparison test was used to determine the significance of the data between groups (**<italic>P</italic>&#x2009;&lt;&#x2009;0.01).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1346565-g005.tif"/>
</fig>
<p>In addition, for formation of mixed biofilms, sfGFP-labelled strains of <italic>S. maltophilia</italic> were incubated in 8-well &#xb5;-Slide chambers with wild-type, tdTomato-labelled <italic>P. aeruginosa</italic> strain PAO1 (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). We chose the BHI medium because it has proven to be the most robust medium for studying <italic>in vitro</italic> biofilm formation of a wide range of bacteria. We had previously shown that <italic>S. maltophilia</italic> and <italic>P. aeruginosa</italic> do not compete with each other under standard laboratory culture conditions and that <italic>S. maltophilia</italic> strains are not sensitive to compounds exogenously produced by <italic>P. aeruginosa</italic> (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;8</bold>
</xref>). As observed in the <italic>S. maltophilia</italic> monospecies biofilms with EDTA, the mutant &#x394;<italic>mlaF-B</italic> also formed less biofilm in the presence of <italic>P. aeruginosa</italic>, although in this case biofilm formation was even more impaired (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). In the competition assays, we observed that when the mixed culture conditions were static (without shaking), the planktonic population of <italic>S. maltophilia</italic> was reduced by one log order, but this was equally the case for all strains examined (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;8D</bold>
</xref>). Interestingly, biomass quantification of the 72-hours biofilms showed that <italic>P. aeruginosa</italic> cells were also affected in the mixed biofilm in the presence of the mutant &#x394;<italic>mlaF-B</italic> (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>), which seems to indicate a bidirectional effect.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Mutation in the Mla system of <italic>S. maltophilia</italic> reduces the biomass of mixed biofilm with <italic>P. aeruginosa</italic>. <bold>(A)</bold> CLSM images of dual species biofilms of sfGFP-labelled <italic>S. maltophilia</italic> K279a strains (green) and <italic>P. aeruginosa</italic> PAO1::tdTomato (red) formed after incubation for 72 hours in 0.5 &#xd7; BHI at 30&#xb0;C. Complementation plasmid pBBR1MCS1-<italic>mlaF-B</italic> is indicated as p<italic>mlaF-B</italic>. <bold>(B)</bold> Quantification of fluorescence signals derived from CLSM 3D images. Data are means &#xb1; SD (n = 3). Two-way ANOVA with <italic>post hoc</italic> Bonferroni&#x2019;s multiple comparison test was used to determine the significance of the data between groups (**<italic>P</italic>&#x2009;&lt;&#x2009;0.01; ***<italic>P</italic>&#x2009;&lt;&#x2009;0.001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1346565-g006.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>The Mla system in Gram-negative bacteria is involved in the transport of PLs between the outer and inner membranes, maintaining OM asymmetry, where PLs are primarily found in the inner leaflet, thus avoiding the formation of misplaced PL patches in the OM outer leaflet (<xref ref-type="bibr" rid="B57">Malinverni and Silhavy, 2009</xref>; <xref ref-type="bibr" rid="B42">Henderson et&#xa0;al., 2016</xref>). However, this is not the only mechanism involved in OM lipid homeostasis, and this is likely the reason of the weak phenotypes observed in mutants with defects in the Mla system, including those shown in this work. For example, the phospholipase PldA of <italic>E. coli</italic> degrades mislocalized PLs for transport of the fatty acids to the cytoplasm for their recycling (<xref ref-type="bibr" rid="B80">Snijder and Dijkstra, 2000</xref>; <xref ref-type="bibr" rid="B57">Malinverni and Silhavy, 2009</xref>). In <italic>S. maltophilia</italic> K279a, the phospholipase A Smlt3218 is an ortholog of <italic>E. coli</italic> PldA (53% similarity, 89% coverage), and may partly compensate for the lack of the Mla system in the mutant. In species that lack PldA, such as <italic>P. aeruginosa</italic>, a new compensatory system named MlaZ/MlaY has recently been discovered (<xref ref-type="bibr" rid="B37">Guest et&#xa0;al., 2023</xref>). This system consists of a lipase and a MlaA-like protein and coordinates the removal of misplaced PL in the OM. A similar system has not been detected by sequence homology in <italic>S. maltophilia</italic>. Although several systems exist to control the lipid composition of the OM, we provide evidence of some physiological consequences of the deletion of the Mla system in <italic>S. maltophilia</italic>.</p>
<p>We have shown that the Mla system helps in making the membrane less permeable to harmful substances, as has been observed for other Gram-negative bacteria (<xref ref-type="bibr" rid="B57">Malinverni and Silhavy, 2009</xref>; <xref ref-type="bibr" rid="B12">Bernier et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B29">Fern&#xe1;ndez-Calvet et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B9">Baarda et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B52">Kamischke et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B22">de Jonge et&#xa0;al., 2022</xref>), and that this role affects physiological aspects of these bacteria and their interaction with other microorganisms. Among the interfering agents evaluated, the action of divalent-ion chelators stood out as the most sensitive to the Mla function. Antibacterial agents such as bile salts, for example, are known to disrupt bacterial membranes and chelate iron and calcium (<xref ref-type="bibr" rid="B88">Urdaneta and Casades&#xfa;s, 2017</xref>). Regarding antibiotic resistance phenotypes, the lack of the Mla system in <italic>S. maltophilia</italic> increased only the susceptibility to colistin and minocycline. Previous studies in <italic>P. aeruginosa</italic> have shown that mutations in the MlaC system have minimal or no impact on those antibiotics to which bacterial strains are equipped with specific mechanisms that confer high-level resistance (<xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>). <italic>S. maltophilia</italic> are intrinsically resistant to multiple antibiotics, including the K279a strain used in this work. However, this strain can be considered susceptible to minocycline and it displays a low resistance to colistin compared to other strains (<xref ref-type="bibr" rid="B94">Yero et&#xa0;al., 2020</xref>). Furthermore, the role of the MlaC system in antibiotic resistance is clearly associated with the PL composition of the OM. It is known that the proportion of the different PL classes in the OM can alter the susceptibility of bacteria to certain antibiotics, e.g. by forming PL patches or changing the structure of integral membrane proteins such as efflux pumps (<xref ref-type="bibr" rid="B11">Bernal et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B26">Epand et&#xa0;al., 2008</xref>).</p>
<p>The soluble periplasmic PL-binding component of the Mla system is the MlaC protein. The role of this protein in PL transport has been extensively discussed in the literature (<xref ref-type="bibr" rid="B27">Ercan et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Hughes et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B92">Yeow et&#xa0;al., 2023</xref>), and it has already been shown to have affinity for several PL classes (<xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>). The low affinity for binding free PL shown in this work is consistent with the results obtained by <xref ref-type="bibr" rid="B49">Hughes et&#xa0;al. (2019)</xref> and may be related the fact that MlaC requires helper proteins to some extend for PL uptake and release. MlaC passes PLs between MlaA and MlaD, acting as a transporter in the periplasm (<xref ref-type="bibr" rid="B81">Tang et&#xa0;al., 2021</xref>), and both proteins appear to be separately required to pass PLs to MlaC (<xref ref-type="bibr" rid="B84">Thong et&#xa0;al., 2016</xref>). On the other hand, structural studies and molecular dynamics simulations on apo and PL&#x2010;bound MlaC show that the binding pocket can be in an open or closed state and suggest that the apo conformation does not easily shift to the open conformation (<xref ref-type="bibr" rid="B45">Huang et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B49">Hughes et&#xa0;al., 2019</xref>). In addition, our work and common sense suggest that the affinity for different PLs is tailored to the PL composition of each species. This affinity is governed by the hydrophobic chains of the fatty acids and not by the nature of the polar head of the PLs, since this is exposed to the medium (<xref ref-type="bibr" rid="B45">Huang et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B93">Yero et&#xa0;al., 2021</xref>). Although the MST and nanoDSF experiments only indicate a potential binding with PE C14:0/C14:0, the preference for PLs with 14-carbon-atom fatty acids deserves to be discussed. Unlike other bacterial families, the most abundant fatty acid in <italic>S. maltophilia</italic> is 13-methyl-tetradecanoic acid (iso-15:0) (<xref ref-type="bibr" rid="B48">Huedo et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B20">Coves et&#xa0;al., 2023</xref>), a branched-chain saturated fatty acid. Our MlaC 3D structure predictions indicate a potential evolution of this system to accommodate branched PLs fatty acids. The co-evolution of the Mla system in Gram-negative bacteria with the PL composition of the membrane indeed deserves further investigation.</p>
<p>In this work, we have also shown that the cooperation between <italic>S. maltophilia</italic> and <italic>P. aeruginosa</italic> in the formation of mixed biofilms depends, in part, on <italic>S. maltophilia</italic> membrane permeability, mediated by the Mla system. Previous <italic>in vitro</italic> studies have shown that both microorganisms are able to live in integrated communities forming polymicrobial biofilms (<xref ref-type="bibr" rid="B77">Ryan et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B62">McDaniel et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B5">Alio et&#xa0;al., 2023</xref>), although this cooperation may be strain specific (<xref ref-type="bibr" rid="B71">Pompilio et&#xa0;al., 2015</xref>). The cooperation seen between <italic>P. aeruginosa</italic> and <italic>S. maltophilia</italic> is primarily attributed to the QS systems of both species. The synthesis and secretion of DSF by <italic>S. maltophilia</italic> affects the expression of stress-response factors in <italic>P. aeruginosa</italic>, such as regulatory systems controlling resistance to polymyxin and antimicrobial peptides (<xref ref-type="bibr" rid="B77">Ryan et&#xa0;al., 2008</xref>). On the other hand, <italic>S. maltophilia</italic> cells can respond to acyl-homoserine lactone (AHL) signals secreted by <italic>P. aeruginosa</italic> that affect their motility (<xref ref-type="bibr" rid="B60">Mart&#xed;nez et&#xa0;al., 2015</xref>). Furthermore, as for other microorganisms, alginate produced by <italic>P. aeruginosa</italic> could provide mechanical or chemical protection for <italic>S. maltophilia</italic> in mixed biofilms (<xref ref-type="bibr" rid="B71">Pompilio et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B62">McDaniel et&#xa0;al., 2020</xref>). Surprisingly, expression of genes of the <italic>mla</italic> operon in <italic>S. maltophilia</italic> K279a was upregulated when cells were in the exponential phase of growth compared to the stationary phase (<xref ref-type="bibr" rid="B20">Coves et&#xa0;al., 2023</xref>). This could indicate that this system is controlled by cell density-dependent mechanisms, such as quorum sensing. In <italic>S. maltophilia</italic> many virulence features, such as extracellular enzymes, bacterial motility and biofilm formation, are finely controlled by its DSF-dependent quorum sensing system (<xref ref-type="bibr" rid="B47">Huedo et&#xa0;al., 2018</xref>). However, DSF production in the Mla system mutant was not affected, suggesting that the regulation of the expression of these genes is under the control of other cellular mechanisms that are modulated in the stationary phase.</p>
<p>The role of the Mla system in protecting cells from divalent-ion chelating agents could explain the results obtained for both axenic and polymicrobial biofilms. Divalent cations stabilize the biofilm as they contribute to cross-linking the matrix through electrostatic interactions (<xref ref-type="bibr" rid="B16">Cavaliere et&#xa0;al., 2014</xref>). The observation of EDTA-induced impairment of biofilm formation in the Mla mutant strain illustrates this relation. On the other hand, extracellular DNA and exopolysaccharides, the main components of the biofilm matrix in <italic>P. aeruginosa</italic>, can act as cation chelators due to their highly anionic character (<xref ref-type="bibr" rid="B44">Horsman et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B91">Wilton et&#xa0;al., 2016</xref>), which may explain the abrupt decrease in biofilm formation by <italic>S. maltophilia</italic> in the presence of <italic>P. aeruginosa</italic>. Besides chelators, the Mla system of <italic>S. maltophilia</italic> may help protect this species from other known harmful effectors of <italic>P. aeruginosa</italic>. For example, <italic>P. aeruginosa</italic> secretes small molecules that can permeabilize bacterial membranes (<xref ref-type="bibr" rid="B74">Radlinski et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B67">Orazi et&#xa0;al., 2019</xref>). In addition, many other studies have shown that <italic>P. aeruginosa</italic> is able to displace other microorganisms in co-cultures <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B35">Gomes-Fernandes et&#xa0;al., 2022</xref>), mainly through the action of exoproducts such as the QS signal 2-heptyl-4-hydroxyquinoline-<italic>N</italic>-oxide (HQNO), siderophores and other antimicrobial compounds that interfere with the growth of other species by competing for the availability of oxygen or affecting the respiratory chain (<xref ref-type="bibr" rid="B13">Biswas et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B2">Abisado et&#xa0;al., 2018</xref>). The Mla system in <italic>S. maltophilia</italic> may help to prevent the entry of these interfering molecules into cells while regulating the diffusion of hydrophobic heterologous QS autoinducers. It has been postulated that the Mla system contributes to the regulation of glycerophospholipid bilayer composition in the OM through which lipophilic molecules can pass (<xref ref-type="bibr" rid="B22">de Jonge et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B37">Guest et&#xa0;al., 2023</xref>). An increased diffusion of certain molecules in the <italic>S. maltophilia</italic> mutant could explain the reduction seen in biomass of <italic>P. aeruginosa</italic> in the mixed biofilm, although this requires further investigation.</p>
<p>The results of this work reinforce the idea that the Mla system could be an interesting target for new antimicrobial strategies. For example, a drug aimed at inhibiting this system could mimic the known synergistic effects of EDTA with antibiotics. EDTA in combination with antibiotics of various classes or disinfectants has been shown to be effective against clinical strains of <italic>S. maltophilia</italic> or for the decontamination of medical devices (<xref ref-type="bibr" rid="B70">Passerini de Rossi et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B7">Anari et&#xa0;al., 2022</xref>). An antimicrobial therapy based on the MlaC transporter is also very attractive to eradicate polymicrobial biofilms formed by Gram-negative pathogens. Although the incidence is very low, there are reports of patients simultaneously infected with <italic>S. maltophilia</italic> and <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="B89">Wainwright et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B95">Yin et&#xa0;al., 2017</xref>). This co-infection appears to have a synergic effect on the mortality and clinical outcome of pneumonia patients (<xref ref-type="bibr" rid="B95">Yin et&#xa0;al., 2017</xref>), which has also been suggested in experimental respiratory infections of mice (<xref ref-type="bibr" rid="B62">McDaniel et&#xa0;al., 2020</xref>).</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>XC: Investigation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Conceptualization. UM: Investigation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. OC: Investigation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Software. PH: Investigation, Writing &#x2013; review &amp; editing. MB: Investigation, Writing &#x2013; review &amp; editing. AG: Investigation, Writing &#x2013; review &amp; editing. IK: Investigation, Writing &#x2013; review &amp; editing. WS: Writing &#x2013; review &amp; editing, Supervision. US: Supervision, Writing&#xa0;&#x2013; review &amp; editing. IG: Conceptualization, Investigation, Supervision, Writing &#x2013; review &amp; editing. XD: Supervision, Writing &#x2013; review &amp; editing, Conceptualization, Investigation. DY: Writing &#x2013; review&#xa0;&amp; editing, Conceptualization, Investigation, Writing &#x2013; original draft.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by the Spanish MICINN (PID2019-111364RB-I00). Authors also thank Catalan AGAUR (2017 SGR1062 and 2021 SGR00092). UM and US acknowledge support from the Leibniz Association (grant SAS-2021-1-FZB of the Leibniz Research Alliance INFECTIONS in an Urbanizing World -Humans, Animals, Environments). WS acknowledge funding from UHH.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Manuel Hein and D&#xf6;rte Grella (RCB) for expert technical assistance, as well as the Fluorescence Cytometry Core Facility of the RCB for continuous support. The authors would like to thank Karen Dehn (IPM - Institute of Plant Sciences and Microbiology) and Renate Walter (Zoological Institute) for their assistance with scanning electron microscopy images, as well as Elke Woelken (IPM) for her help with transmission electron microscopy.</p>
</ack>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2024.1346565/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2024.1346565/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abda</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Krysciak</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Krohn-Molt</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Mamat</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Schmeisser</surname> <given-names>C.</given-names>
</name>
<name>
<surname>F&#xf6;rstner</surname> <given-names>K. U.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Phenotypic heterogeneity affects <italic>Stenotrophomonas maltophilia</italic> K279a colony morphotypes and &#x3b2;-lactamase expression</article-title>. <source>Front. Microbiol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2015.01373</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abisado</surname> <given-names>R. G.</given-names>
</name>
<name>
<surname>Benomar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Klaus</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Dandekar</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Chandler</surname> <given-names>J. R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Bacterial quorum sensing and microbial community interactions</article-title>. <source>mBio</source> <volume>9</volume>, <fpage>e02331</fpage>&#x2013;<lpage>e02317</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.02331-17</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alcaraz</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Garc&#xed;a</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Friedman</surname> <given-names>L.</given-names>
</name>
<name>
<surname>de Rossi</surname> <given-names>B. P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The rpf/DSF signalling system of <italic>Stenotrophomonas maltophilia</italic> positively regulates biofilm formation, production of virulence-associated factors and &#x3b2;-lactamase induction</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>366</volume>, <elocation-id>fnz069</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/femsle/fnz069</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alio</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Gudzuhn</surname> <given-names>M.</given-names>
</name>
<name>
<surname>P&#xe9;rez Garc&#xed;a</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Danso</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Schoelmerich</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Mamat</surname> <given-names>U.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Phenotypic and transcriptomic analyses of seven clinical <italic>Stenotrophomonas maltophilia</italic> isolates identify a small set of shared and commonly regulated genes involved in the biofilm lifestyle</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>86</volume>, <fpage>e02038</fpage>&#x2013;<lpage>e02020</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.02038-20</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alio</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Moll</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Mamat</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Schaible</surname> <given-names>U. E.</given-names>
</name>
<name>
<surname>Pappenfort</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>
<italic>Stenotrophomonas maltophilia</italic> affects the gene expression profiles of the major pathogens <italic>Pseudomonas aeruginosa</italic> and <italic>Staphylococcus aureus</italic> in an in <italic>vitro</italic> multispecies biofilm model</article-title>. <source>Microbiol. Spectr.</source> <volume>11</volume>, <fpage>e0085923</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/spectrum.00859-23</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alm</surname> <given-names>E. J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>K. H.</given-names>
</name>
<name>
<surname>Price</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Koche</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Keller</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Dubchak</surname> <given-names>I. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>The MicrobesOnline Web site for comparative genomics</article-title>. <source>Genome Res.</source> <volume>15</volume>, <fpage>1015</fpage>&#x2013;<lpage>1022</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gr.3844805</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anari</surname> <given-names>R. K.</given-names>
</name>
<name>
<surname>Nikkhahi</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Javadi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bakht</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Rostamani</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kelishomi</surname> <given-names>F. Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Evaluation of antibacterial activity of five biocides and the synergistic effect of biocide/EDTA combinations on biofilm-producing and non-producing <italic>Stenotrophomonas maltophilia</italic> strains isolated from clinical specimens in Iran</article-title>. <source>BMC Microbiol.</source> <volume>22</volume>, <fpage>257</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12866-022-02664-1</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aubert</surname> <given-names>D. F.</given-names>
</name>
<name>
<surname>Hamad</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Valvano</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>A markerless deletion method for genetic manipulation of <italic>Burkholderia cenocepacia</italic> and other multidrug-resistant gram-negative bacteria</article-title>. <source>Methods Mol. Biol.</source> <volume>1197</volume>, <fpage>311</fpage>&#x2013;<lpage>327</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-4939-1261-2_18</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baarda</surname> <given-names>B. I.</given-names>
</name>
<name>
<surname>Zielke</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Van</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Jerse</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Sikora</surname> <given-names>A. E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Neisseria gonorrhoeae</italic> MlaA influences gonococcal virulence and membrane vesicle production</article-title>. <source>PloS Pathog.</source> <volume>15</volume>, <fpage>e1007385</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1007385</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lies</surname> <given-names>D. P.</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>G. P.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>An improved Tn7-based system for the single-copy insertion of cloned genes into chromosomes of gram-negative bacteria</article-title>. <source>Gene</source> <volume>109</volume>, <fpage>167</fpage>&#x2013;<lpage>168</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0378-1119(91)90604-A</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernal</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Mu&#xf1;oz-Rojas</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hurtado</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ramos</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Segura</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>A <italic>Pseudomonas putida</italic> cardiolipin synthesis mutant exhibits increased sensitivity to drugs related to transport functionality</article-title>. <source>Environ. Microbiol.</source> <volume>9</volume>, <fpage>1135</fpage>&#x2013;<lpage>1145</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-2920.2006.01236.x</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernier</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Son</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Surette</surname> <given-names>M. G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Mla pathway plays an essential role in the intrinsic resistance of <italic>Burkholderia cepacia</italic> complex species to antimicrobials and host innate components</article-title>. <source>J. Bacteriol.</source> <volume>200</volume>, <fpage>e00156</fpage>&#x2013;<lpage>e00118</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.00156-18</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Biswas</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Schlag</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bertram</surname> <given-names>R.</given-names>
</name>
<name>
<surname>G&#xf6;tz</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Small-colony variant selection as a survival strategy for <italic>Staphylococcus aureus</italic> in the presence of <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>75</volume>, <fpage>6910</fpage>&#x2013;<lpage>6912</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.01211-09</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brooke</surname> <given-names>J. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Advances in the microbiology of <italic>Stenotrophomonas maltophilia</italic>
</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>34</volume>, <fpage>e0003019</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00030-19</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caspi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Billington</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ferrer</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Foerster</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Fulcher</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Keseler</surname> <given-names>I. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases</article-title>. <source>Nucleic Acids Res.</source> <volume>44</volume>, <fpage>D471</fpage>&#x2013;<lpage>D480</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkv1164</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavaliere</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ball</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Turnbull</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Whitchurch</surname> <given-names>C. B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The biofilm matrix destabilizers, EDTA and DNaseI, enhance the susceptibility of nontypeable <italic>Hemophilus influenzae</italic> biofilms to treatment with ampicillin and ciprofloxacin</article-title>. <source>Microbiologyopen</source> <volume>3</volume>, <fpage>557</fpage>&#x2013;<lpage>567</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mbo3.187</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname> <given-names>K.-H.</given-names>
</name>
<name>
<surname>Schweizer</surname> <given-names>H. P.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>mini-Tn7 insertion in bacteria with single attTn7 sites: example <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Nat. Protoc.</source> <volume>1</volume>, <fpage>153</fpage>&#x2013;<lpage>161</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nprot.2006.24</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname> <given-names>Z.-S.</given-names>
</name>
<name>
<surname>Woo</surname> <given-names>W.-F.</given-names>
</name>
<name>
<surname>Chng</surname> <given-names>S.-S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Osmoporin OmpC forms a complex with MlaA to maintain outer membrane lipid asymmetry in <italic>Escherichia coli</italic>
</article-title>. <source>Mol. Microbiol.</source> <volume>98</volume>, <fpage>1133</fpage>&#x2013;<lpage>1146</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/mmi.13202</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="book">
<person-group person-group-type="author">
<collab>CLSI</collab>
</person-group> (<year>2015</year>). <source>Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 10th edition. M07 A10</source> (<publisher-loc>Wayne, PA</publisher-loc>: <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>).</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coves</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Bravo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Huedo</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Conchillo-Sol&#xe9;</surname> <given-names>&#xd2;.</given-names>
</name>
<name>
<surname>G&#xf3;mez</surname> <given-names>A.-C.</given-names>
</name>
<name>
<surname>Esteve-Codina</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>A <italic>Stenotrophomonas maltophilia</italic> TetR-like transcriptional regulator involved in fatty acid metabolism is controlled by quorum sensing signals</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>89</volume>, <fpage>e0063523</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aem.00635-23</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daims</surname> <given-names>H.</given-names>
</name>
<name>
<surname>L&#xfc;cker</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wagner</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>
<italic>daime</italic>, a novel image analysis program for microbial ecology and biofilm research</article-title>. <source>Environ. Microbiol.</source> <volume>8</volume>, <fpage>200</fpage>&#x2013;<lpage>213</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-2920.2005.00880.x</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Jonge</surname> <given-names>E. F.</given-names>
</name>
<name>
<surname>Vogrinec</surname> <given-names>L.</given-names>
</name>
<name>
<surname>van Boxtel</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Tommassen</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Inactivation of the Mla system and outer-membrane phospholipase A results in disrupted outer-membrane lipid asymmetry and hypervesiculation in <italic>Bordetella pertussis</italic>
</article-title>. <source>Curr. Res. Microb. Sci.</source> <volume>3</volume>, <elocation-id>100172</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.crmicr.2022.100172</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devos</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Van Oudenhove</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Stremersch</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Van Putte</surname> <given-names>W.</given-names>
</name>
<name>
<surname>De Rycke</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Van Driessche</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in <italic>Stenotrophomonas maltophilia</italic>
</article-title>. <source>Front. Microbiol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2015.00298</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dudek</surname> <given-names>C.-A.</given-names>
</name>
<name>
<surname>Jahn</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>PRODORIC: state-of-the-art database of prokaryotic gene regulation</article-title>. <source>Nucleic Acids Res.</source> <volume>50</volume>, <fpage>D295</fpage>&#x2013;<lpage>D302</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkab1110</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ekiert</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Bhabha</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Isom</surname> <given-names>G. L.</given-names>
</name>
<name>
<surname>Greenan</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Ovchinnikov</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Henderson</surname> <given-names>I. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Architectures of lipid transport systems for the bacterial outer membrane</article-title>. <source>Cell</source> <volume>169</volume>, <fpage>273</fpage>&#x2013;<lpage>285.e17</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2017.03.019</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Epand</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Rotem</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mor</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Berno</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Epand</surname> <given-names>R. F.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Bacterial membranes as predictors of antimicrobial potency</article-title>. <source>J. Am. Chem. Soc.</source> <volume>130</volume>, <fpage>14346</fpage>&#x2013;<lpage>14352</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/ja8062327</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ercan</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Low</surname> <given-names>W.-Y.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Chng</surname> <given-names>S.-S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Characterization of interactions and phospholipid transfer between substrate binding proteins of the OmpC-Mla system</article-title>. <source>Biochemistry</source> <volume>58</volume>, <fpage>114</fpage>&#x2013;<lpage>119</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acs.biochem.8b00897</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fern&#xe1;ndez</surname> <given-names>L.</given-names>
</name>
<name>
<surname>&#xc1;lvarez-Ortega</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Olivares</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lam</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Koc&#xed;ncov&#xe1;</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Wiegand</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Characterization of the polymyxin B resistome of <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>57</volume>, <fpage>110</fpage>&#x2013;<lpage>119</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aac.01583-12</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fern&#xe1;ndez-Calvet</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Arce</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Almagro</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Moleres</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Euba</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Caballero</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Modulation of <italic>Haemophilus influenzae</italic> interaction with hydrophobic molecules by the VacJ/MlaA lipoprotein impacts strongly on its interplay with the airways</article-title>. <source>Sci. Rep.</source> <volume>8</volume>, <fpage>6872</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-018-25232-y</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Figurski</surname> <given-names>D. H.</given-names>
</name>
<name>
<surname>Helinski</surname> <given-names>D. R.</given-names>
</name>
</person-group> (<year>1979</year>). <article-title>Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>76</volume>, <fpage>1648</fpage>&#x2013;<lpage>1652</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.76.4.1648</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flannagan</surname> <given-names>R. S.</given-names>
</name>
<name>
<surname>Linn</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Valvano</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>A system for the construction of targeted unmarked gene deletions in the genus <italic>Burkholderia</italic>
</article-title>. <source>Environ. Microbiol.</source> <volume>10</volume>, <fpage>1652</fpage>&#x2013;<lpage>1660</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-2920.2008.01576.x</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flores-Trevi&#xf1;o</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bocanegra-Ibarias</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Camacho-Ortiz</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Morf&#xed;n-Otero</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Salazar-Sesatty</surname> <given-names>H. A.</given-names>
</name>
<name>
<surname>Garza-Gonz&#xe1;lez</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Stenotrophomonas maltophilia</italic> biofilm: its role in infectious diseases</article-title>. <source>Expert Rev. Anti Infect. Ther</source>. <volume>17</volume>, <fpage>877</fpage>&#x2013;<lpage>893</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14787210.2019.1685875</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gidden</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Denson</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liyanage</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ivey</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Lay</surname> <given-names>J. O.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Lipid compositions in <italic>Escherichia coli</italic> and <italic>Bacillus subtilis</italic> during growth as determined by MALDI-TOF and TOF/TOF mass spectrometry</article-title>. <source>Int. J. Mass Spectrom</source> <volume>283</volume>, <fpage>178</fpage>&#x2013;<lpage>184</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijms.2009.03.005</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gil-Gil</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Mart&#xed;nez</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Blanco</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mechanisms of antimicrobial resistance in <italic>Stenotrophomonas maltophilia</italic>: a review of current knowledge</article-title>. <source>Expert Rev. Anti Infect. Ther.</source> <volume>18</volume>, <fpage>335</fpage>&#x2013;<lpage>347</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14787210.2020.1730178</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes-Fernandes</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gomez</surname> <given-names>A.-C.</given-names>
</name>
<name>
<surname>Bravo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Huedo</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Coves</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Prat-Aymerich</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Strain-specific interspecies interactions between co-isolated pairs of <italic>Staphylococcus aureus</italic> and <italic>Pseudomonas aeruginosa</italic> from patients with tracheobronchitis or bronchial colonization</article-title>. <source>Sci. Rep.</source> <volume>12</volume>, <fpage>3374</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-022-07018-5</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gr&#xf6;schel</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Meehan</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Barilar</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Diricks</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gonzaga</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Steglich</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist <italic>Stenotrophomonas maltophilia</italic>
</article-title>. <source>Nat. Commun.</source> <volume>11</volume>, <fpage>2044</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-020-15123-0</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guest</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Silhavy</surname> <given-names>T. J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>A periplasmic phospholipase that maintains outer membrane lipid asymmetry in <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>120</volume>, <fpage>e2302546120</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2302546120</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guzman</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Belin</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Carson</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Beckwith</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter</article-title>. <source>J. Bacteriol.</source> <volume>177</volume>, <fpage>4121</fpage>&#x2013;<lpage>4130</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.177.14.4121-4130.1995</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamad</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Skeldon</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Valvano</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Construction of aminoglycoside-sensitive <italic>Burkholderia cenocepacia</italic> strains for use in studies of intracellular bacteria with the gentamicin protection assay</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>76</volume>, <fpage>3170</fpage>&#x2013;<lpage>3176</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.03024-09</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanahan</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Studies on transformation of <italic>Escherichia coli</italic> with plasmids</article-title>. <source>J. Mol. Biol.</source> <volume>166</volume>, <fpage>557</fpage>&#x2013;<lpage>580</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0022-2836(83)80284-8</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helander</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Mattila-Sandholm</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Fluorometric assessment of Gram-negative bacterial permeabilization</article-title>. <source>J. Appl. Microbiol.</source> <volume>88</volume>, <fpage>213</fpage>&#x2013;<lpage>219</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2672.2000.00971.x</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henderson</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Zimmerman</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Crofts</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Boll</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Kuhns</surname> <given-names>L. G.</given-names>
</name>
<name>
<surname>Herrera</surname> <given-names>C. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>The power of asymmetry: architecture and assembly of the gram-negative outer membrane lipid bilayer</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>70</volume>, <fpage>255</fpage>&#x2013;<lpage>278</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-micro-102215-095308</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holm</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Benchmarking fold detection by DaliLite v.5</article-title>. <source>Bioinformatics</source> <volume>35</volume>, <fpage>5326</fpage>&#x2013;<lpage>5327</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btz536</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horsman</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Lewenza</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Calcium chelation by alginate activates the type III secretion system in mucoid <italic>Pseudomonas aeruginosa</italic> biofilms</article-title>. <source>PloS One</source> <volume>7</volume>, <fpage>e46826</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0046826</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>Y.-M. M.</given-names>
</name>
<name>
<surname>Miao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Munguia</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Nizet</surname> <given-names>V.</given-names>
</name>
<name>
<surname>McCammon</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Molecular dynamic study of MlaC protein in Gram-negative bacteria: conformational flexibility, solvent effect and protein-phospholipid binding</article-title>. <source>Protein Sci.</source> <volume>25</volume>, <fpage>1430</fpage>&#x2013;<lpage>1437</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/pro.2939</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>T.-P.</given-names>
</name>
<name>
<surname>Somers</surname> <given-names>E. B.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>A. C. L.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Differential biofilm formation and motility associated with lipopolysaccharide/exopolysaccharide-coupled biosynthetic genes in <italic>Stenotrophomonas maltophilia</italic>
</article-title>. <source>J. Bacteriol.</source> <volume>188</volume>, <fpage>3116</fpage>&#x2013;<lpage>3120</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.188.8.3116-3120.2006</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huedo</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Coves</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Daura</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Gibert</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Yero</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Quorum sensing signaling and quenching in the multidrug-resistant pathogen <italic>Stenotrophomonas maltophilia</italic>
</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2018.00122</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huedo</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Yero</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Martinez-Servat</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ruyra</surname> <given-names>&#xc0;.</given-names>
</name>
<name>
<surname>Roher</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Daura</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Decoding the genetic and functional diversity of the DSF quorum-sensing system in <italic>Stenotrophomonas maltophilia</italic>
</article-title>. <source>Front. Microbiol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2015.00761</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname> <given-names>G. W.</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>S. C. L.</given-names>
</name>
<name>
<surname>Laxton</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Sridhar</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Mahadi</surname> <given-names>A. H.</given-names>
</name>
<name>
<surname>Hatton</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Evidence for phospholipid export from the bacterial inner membrane by the Mla ABC transport system</article-title>. <source>Nat. Microbiol.</source> <volume>4</volume>, <fpage>1692</fpage>&#x2013;<lpage>1705</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-019-0481-y</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hutchinson</surname> <given-names>E. G.</given-names>
</name>
<name>
<surname>Thornton</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>A revised set of potentials for beta-turn formation in proteins</article-title>. <source>Protein Sci.</source> <volume>3</volume>, <fpage>2207</fpage>&#x2013;<lpage>2216</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/pro.5560031206</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jumper</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Pritzel</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Green</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Figurnov</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ronneberger</surname> <given-names>O.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>. <source>Nature</source> <volume>596</volume>, <fpage>583</fpage>&#x2013;<lpage>589</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamischke</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bergeron</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kulasekara</surname> <given-names>H. D.</given-names>
</name>
<name>
<surname>Dalebroux</surname> <given-names>Z. D.</given-names>
</name>
<name>
<surname>Burrell</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>The <italic>Acinetobacter baumannii</italic> Mla system and glycerophospholipid transport to the outer membrane</article-title>. <source>Elife</source> <volume>8</volume>, <fpage>e40171</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.40171</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovach</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Elzer</surname> <given-names>P. H.</given-names>
</name>
<name>
<surname>Roop</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Peterson</surname> <given-names>K. M.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>pBBR1MCS: a broad-host-range cloning vector</article-title>. <source>Biotechniques</source> <volume>16</volume>, <fpage>800</fpage>&#x2013;<lpage>802</lpage>.</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loh</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Grant</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Hancock</surname> <given-names>R. E. W.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>26</volume>, <fpage>546</fpage>&#x2013;<lpage>551</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.26.4.546</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundstedt</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Kahne</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ruiz</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Assembly and maintenance of lipids at the bacterial outer membrane</article-title>. <source>Chem. Rev.</source> <volume>121</volume>, <fpage>5098</fpage>&#x2013;<lpage>5123</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acs.chemrev.0c00587</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majumdar</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Karthikeyan</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Senthilnathan</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Sugumar</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Review on <italic>Stenotrophomonas maltophilia</italic>: An emerging multidrug- resistant opportunistic pathogen</article-title>. <source>Recent Pat. Biotechnol.</source> <volume>16</volume>, <fpage>329</fpage>&#x2013;<lpage>354</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1872208316666220512121205</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malinverni</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Silhavy</surname> <given-names>T. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>An ABC transport system that maintains lipid asymmetry in the gram-negative outer membrane</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>106</volume>, <fpage>8009</fpage>&#x2013;<lpage>8014</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0903229106</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mamat</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Hein</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Grella</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Scholzen</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Alio</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Improved mini-Tn7 Delivery Plasmids for Fluorescent Labeling of <italic>Stenotrophomonas maltophilia</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>89</volume>, <fpage>e0031723</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/aem.00317-23</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maraolo</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Licciardi</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Gentile</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Saracino</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Belati</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bavaro</surname> <given-names>D. F.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>
<italic>Stenotrophomonas maltophilia</italic> infections: A systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options</article-title>. <source>Antibiotics (Basel)</source> <volume>12</volume>, <elocation-id>910</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antibiotics12050910</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#xed;nez</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Huedo</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Martinez-Servat</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Planell</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ferrer-Navarro</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Daura</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>
<italic>Stenotrophomonas maltophilia</italic> responds to exogenous AHL signals through the LuxR solo SmoR (Smlt1839)</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2015.00041</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#xed;nez-Servat</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yero</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Huedo</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Marquez</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Molina</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Daura</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Heterogeneous colistin-resistance phenotypes coexisting in <italic>Stenotrophomonas maltophilia</italic> isolates influence colistin susceptibility testing</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.02871</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDaniel</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Schoeb</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Swords</surname> <given-names>W. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Cooperativity between <italic>Stenotrophomonas maltophilia</italic> and <italic>Pseudomonas aeruginosa</italic> during Polymicrobial Airway Infections</article-title>. <source>Infect. Immun.</source> <volume>88</volume>, <fpage>e00855</fpage>&#x2013;<lpage>e00819</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00855-19</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname> <given-names>V. L.</given-names>
</name>
<name>
<surname>Mekalanos</surname> <given-names>J. J.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in <italic>Vibrio cholerae</italic> requires toxR</article-title>. <source>J. Bacteriol.</source> <volume>170</volume>, <fpage>2575</fpage>&#x2013;<lpage>2583</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.170.6.2575-2583.1988</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mistry</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Finn</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Eddy</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Bateman</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Punta</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Challenges in homology search: HMMER3 and convergent evolution of coiled-coil regions</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume>, <fpage>e121</fpage>&#x2013;<lpage>e121</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkt263</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikaido</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Molecular basis of bacterial outer membrane permeability revisited</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>67</volume>, <fpage>593</fpage>&#x2013;<lpage>656</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MMBR.67.4.593-656.2003</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivares</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bernardini</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Garcia-Leon</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Corona</surname> <given-names>F.</given-names>
</name>
<name>
<surname>B. Sanchez</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>J. L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The intrinsic resistome of bacterial pathogens</article-title>. <source>Front. Microbiol.</source> <volume>4</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2013.00103</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orazi</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Ruoff</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>O&#x2019;Toole</surname> <given-names>G. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Pseudomonas aeruginosa</italic> Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics</article-title>. <source>mBio</source> <volume>10</volume>, <fpage>e01501</fpage>&#x2013;<lpage>e01519</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.01501-19</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oursel</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Loutelier-Bourhis</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Orange</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chevalier</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Norris</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Lange</surname> <given-names>C. M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Lipid composition of membranes of <italic>Escherichia coli</italic> by liquid chromatography/tandem mass spectrometry using negative electrospray ionization</article-title>. <source>Rapid Commun. Mass Spectrom</source> <volume>21</volume>, <fpage>1721</fpage>&#x2013;<lpage>1728</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/rcm.3013</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Overhage</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lewenza</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Marr</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Hancock</surname> <given-names>R. E. W.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Identification of genes involved in swarming motility using a <italic>Pseudomonas aeruginosa</italic> PAO1 mini-Tn5-lux mutant library</article-title>. <source>J. Bacteriol.</source> <volume>189</volume>, <fpage>2164</fpage>&#x2013;<lpage>2169</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.01623-06</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Passerini de Rossi</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Feldman</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Pineda</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Vay</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Franco</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Comparative in <italic>vitro</italic> efficacies of ethanol-, EDTA- and levofloxacin-based catheter lock solutions on eradication of <italic>Stenotrophomonas maltophilia</italic> biofilms</article-title>. <source>J. Med. Microbiol.</source> <volume>61</volume>, <fpage>1248</fpage>&#x2013;<lpage>1253</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/jmm.0.039743-0</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pompilio</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Crocetta</surname> <given-names>V.</given-names>
</name>
<name>
<surname>De Nicola</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Verginelli</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Fiscarelli</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Di Bonaventura</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Cooperative pathogenicity in cystic fibrosis: <italic>Stenotrophomonas maltophilia</italic> modulates <italic>Pseudomonas aeruginosa</italic> virulence in mixed biofilm</article-title>. <source>Front. Microbiol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2015.00951</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powers</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Trent</surname> <given-names>M. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Phospholipid retention in the absence of asymmetry strengthens the outer membrane permeability barrier to last-resort antibiotics</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>115</volume>, <fpage>E8518</fpage>&#x2013;<lpage>E8527</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1806714115</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powers</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Trent</surname> <given-names>M. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Intermembrane transport: Glycerophospholipid homeostasis of the Gram-negative cell envelope</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>116</volume>, <fpage>17147</fpage>&#x2013;<lpage>17155</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1902026116</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radlinski</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Rowe</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Kartchner</surname> <given-names>L. B.</given-names>
</name>
<name>
<surname>Maile</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Cairns</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>Vitko</surname> <given-names>N. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>
<italic>Pseudomonas aeruginosa</italic> exoproducts determine antibiotic efficacy against <italic>Staphylococcus aureus</italic>
</article-title>. <source>PloS Biol.</source> <volume>15</volume>, <fpage>e2003981</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pbio.2003981</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roier</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zingl</surname> <given-names>F. G.</given-names>
</name>
<name>
<surname>Cakar</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Durakovic</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kohl</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Eichmann</surname> <given-names>T. O.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria</article-title>. <source>Nat. Commun.</source> <volume>7</volume>, <elocation-id>10515</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms10515</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rutherford</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Parkhill</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Crook</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Horsnell</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Rice</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Rajandream</surname> <given-names>M. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2000</year>). <article-title>Artemis: sequence visualization and annotation</article-title>. <source>Bioinformatics</source> <volume>16</volume>, <fpage>944</fpage>&#x2013;<lpage>945</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/16.10.944</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryan</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Fouhy</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Garcia</surname> <given-names>B. F.</given-names>
</name>
<name>
<surname>Watt</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Niehaus</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Interspecies signalling via the <italic>Stenotrophomonas maltophilia</italic> diffusible signal factor influences biofilm formation and polymyxin tolerance in <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Mol. Microbiol.</source> <volume>68</volume>, <fpage>75</fpage>&#x2013;<lpage>86</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06132.x</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>S&#xe1;nchez</surname> <given-names>M. B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Antibiotic resistance in the opportunistic pathogen <italic>Stenotrophomonas maltophilia</italic>
</article-title>. <source>Front. Microbiol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2015.00658</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slater</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Alvarez-Morales</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Barber</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>Daniels</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Dow</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>A two-component system involving an HD-GYP domain protein links cell-cell signalling to pathogenicity gene expression in <italic>Xanthomonas campestris</italic>
</article-title>. <source>Mol. Microbiol.</source> <volume>38</volume>, <fpage>986</fpage>&#x2013;<lpage>1003</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.02196.x</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snijder</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Dijkstra</surname> <given-names>B. W.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Bacterial phospholipase A: structure and function of an integral membrane phospholipase</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1488</volume>, <fpage>91</fpage>&#x2013;<lpage>101</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1388-1981(00)00113-X</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Qiao</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Structural insights into outer membrane asymmetry maintenance in Gram-negative bacteria by MlaFEDB</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>28</volume>, <fpage>81</fpage>&#x2013;<lpage>91</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41594-020-00532-y</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="web">
<person-group person-group-type="author">
<collab>The European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute</collab>
</person-group> (<year>2016</year>) <article-title>Recommendations for MIC determination of colistin (polymyxin E) as recommended by the joint CLSI-EUCAST Polymyxin Breakpoints Working Group</article-title>. Available online at: <uri xlink:href="http://www.eucast.org/guidance_documents/">http://www.eucast.org/guidance_documents/</uri>.</citation>
</ref>
<ref id="B83">
<citation citation-type="book">
<person-group person-group-type="author">
<collab>The PyMOL Molecular Graphics System, Version 2.4.2</collab>
</person-group>. (<year>2022</year>) (<publisher-name>Schr&#xf6;dinger, LLC</publisher-name>). Available at: <uri xlink:href="https://pymol.org/2/support.html?">https://pymol.org/2/support.html?</uri>.</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thong</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ercan</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Torta</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Fong</surname> <given-names>Z. Y.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>H. Y. A.</given-names>
</name>
<name>
<surname>Wenk</surname> <given-names>M. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Defining key roles for auxiliary proteins in an ABC transporter that maintains bacterial outer membrane lipid asymmetry</article-title>. <source>Elife</source> <volume>5</volume>, <fpage>e19042</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.19042.022</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>CASTp 3.0: computed atlas of surface topography of proteins</article-title>. <source>Nucleic Acids Res.</source> <volume>46</volume>, <fpage>W363</fpage>&#x2013;<lpage>W367</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gky473</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trifonova</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Strateva</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Stenotrophomonas maltophilia</italic> - a low-grade pathogen with numerous virulence factors</article-title>. <source>Infect. Dis. (Lond)</source> <volume>51</volume>, <fpage>168</fpage>&#x2013;<lpage>178</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/23744235.2018.1531145</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tunyasuvunakool</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Adler</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Green</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Zielinski</surname> <given-names>M.</given-names>
</name>
<name>
<surname>&#x17d;&#xed;dek</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Highly accurate protein structure prediction for the human proteome</article-title>. <source>Nature</source> <volume>596</volume>, <fpage>590</fpage>&#x2013;<lpage>596</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-021-03828-1</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urdaneta</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Casades&#xfa;s</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts</article-title>. <source>Front. Med. (Lausanne)</source> <volume>4</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmed.2017.00163</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wainwright</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>France</surname> <given-names>M. W.</given-names>
</name>
<name>
<surname>O&#x2019;Rourke</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Anuj</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kidd</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Nissen</surname> <given-names>M. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Cough-generated aerosols of <italic>Pseudomonas aeruginosa</italic> and other Gram-negative bacteria from patients with cystic fibrosis</article-title>. <source>Thorax</source> <volume>64</volume>, <fpage>926</fpage>&#x2013;<lpage>931</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/thx.2008.112466</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waterhouse</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Procter</surname> <given-names>J. B.</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>D. M. A.</given-names>
</name>
<name>
<surname>Clamp</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Barton</surname> <given-names>G. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Jalview Version 2&#x2014;a multiple sequence alignment editor and analysis workbench</article-title>. <source>Bioinformatics</source> <volume>25</volume>, <fpage>1189</fpage>&#x2013;<lpage>1191</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btp033</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilton</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>M. J. Q.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Moore</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Parkins</surname> <given-names>M. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Chelation of membrane-bound cations by extracellular DNA activates the type VI secretion system in <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source>Infect. Immun.</source> <volume>84</volume>, <fpage>2355</fpage>&#x2013;<lpage>2361</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00233-16</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeow</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chng</surname> <given-names>S.-S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Molecular mechanism of phospholipid transport at the bacterial outer membrane interface</article-title>. <source>Nat. Commun.</source> <volume>14</volume>, <fpage>8285</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-023-44144-8</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yero</surname> <given-names>D.</given-names>
</name>
<name>
<surname>D&#xed;az-Lobo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Costenaro</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Conchillo-Sol&#xe9;</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Mayo</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ferrer-Navarro</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The <italic>Pseudomonas aeruginosa</italic> substrate-binding protein Ttg2D functions as a general glycerophospholipid transporter across the periplasm</article-title>. <source>Commun. Biol.</source> <volume>4</volume>, <fpage>448</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42003-021-01968-8</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yero</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Huedo</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Conchillo-Sol&#xe9;</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Servat</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mamat</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Coves</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Genetic variants of the DSF quorum sensing system in <italic>Stenotrophomonas maltophilia</italic> influence virulence and resistance phenotypes among genotypically diverse clinical isolates</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2020.01160</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Co-infection of <italic>Pseudomonas aeruginosa</italic> and <italic>Stenotrophomonas maltophilia</italic> in hospitalised pneumonia patients has a synergic and significant impact on clinical outcomes</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source> <volume>36</volume>, <fpage>2231</fpage>&#x2013;<lpage>2235</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10096-017-3050-4</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>